SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: All beta proteins (24004)
(-)
Fold: Immunoglobulin-like beta-sandwich (7299)
(-)
Superfamily: Immunoglobulin (5995)
(-)
Family: V set domains (antibody variable domain-like) (1919)
(-)
Protein domain: Alphaherpesvirus glycoprotein E (2)
(-)
Human herpesvirus 1 [TaxId: 10298] (2)
2GIYA:218-394; B:CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF THE HSV-1 GE ECTODOMAIN
2GJ7E:220-390; F:220-390CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX
(-)
Protein domain: automated matches (311)
(-)
Camel (Camelus dromedarius) [TaxId: 9838] (22)
1YC7A:; B:CABAN33 VHH FRAGMENT AGAINST VSG
1YC8A:; B:CABAN33- Y37V/E44G/R45L TRIPLE MUTANT
1YZZA:; B:HUMANIZED CABAN33 AT ROOM TEMPERATURE
2P42B:; D:COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 1.8A RESOLUTION: SE3-MONO-2 CRYSTAL FORM WITH THREE SE-MET SITES (M34, M51, M83) IN VHH SCAFFOLD
2P43B:COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 1.65A RESOLUTION: SE3-MONO-1 CRYSTAL FORM WITH THREE SE-MET SITES (M34, M51, M83) IN VHH SCAFFOLD
2P44B:COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 1.8A RESOLUTION: SE5A-MONO-1 CRYSTAL FORM WITH FIVE SE-MET SITES (M34, M51, F68M, M83, L86M) IN VHH SCAFFOLD
2P45B:COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 1.1A RESOLUTION: SE5B-ORTHO-1 CRYSTAL FORM WITH FIVE SE-MET SITES (L4M, M34, M51, F68M, M83) IN VHH SCAFFOLD.
2P46B:; D:COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 2.5A RESOLUTION: SE5B-ORTHO-2 CRYSTAL FORM WITH FIVE SE-MET SITES (L4M, M34, M51, F68M, M83) IN VHH SCAFFOLD.
2P47B:COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 2.5A RESOLUTION: SE5B-TRI CRYSTAL FORM WITH FIVE SE-MET SITES (L4M, M34, M51, F68M, M83) IN VHH SCAFFOLD.
2P48B:COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 2.3A RESOLUTION: SE5B-TETRA CRYSTAL FORM WITH FIVE SE-MET SITES (L4M, M34, M51, F68M, M83) IN VHH SCAFFOLD.
2P49B:COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 1.4A RESOLUTION: NATIVE MONO_1 CRYSTAL FORM
2P4AB:; D:X-RAY STRUCTURE OF A CAMELID AFFINITY MATURED SINGLE-DOMAIN VHH ANTIBODY FRAGMENT IN COMPLEX WITH RNASE A
2X6MA:STRUCTURE OF A SINGLE DOMAIN CAMELID ANTIBODY FRAGMENT IN COMPLEX WITH A C-TERMINAL PEPTIDE OF ALPHA-SYNUCLEIN
2X89A:; B:; C:STRUCTURE OF THE BETA2_MICROGLOBULIN INVOLVED IN AMYLOIDOGENESIS
3DWTA:; B:; C:; D:; E:; F:; G:; H:STRUCTURE OF CABBCII-10 NANOBODY
3EAKA:; B:NBBCII10 HUMANIZED (FGLA MUTANT)
3EBAA:CABHUL6 FGLW MUTANT (HUMANIZED) IN COMPLEX WITH HUMAN LYSOZYME
3G9AB:GREEN FLUORESCENT PROTEIN BOUND TO MINIMIZER NANOBODY
3K1KC:; D:GREEN FLUORESCENT PROTEIN BOUND TO ENHANCER NANOBODY
3OGOE:; F:; G:; H:STRUCTURE OF THE GFP:GFP-NANOBODY COMPLEX AT 2.8 A RESOLUTION IN SPACEGROUP P21212
3QSKB:5 HISTIDINE VARIANT OF THE ANTI-RNASE A VHH IN COMPLEX WITH RNASE A
4I0CC:; D:THE STRUCTURE OF THE CAMELID ANTIBODY CABHUL5 IN COMPLEX WITH HUMAN LYSOZYME
(-)
Cow (Bos taurus) [TaxId: 9913] (1)
4KKNA:CRYSTAL STRUCTURE OF BOVINE CTLA-4, PSI-NYSGRC-012704
(-)
Dogfish (Squalus acanthias) [TaxId: 7797] (2)
4HGKC:; D:SHARK IGNAR VARIABLE DOMAIN
4HGMA:SHARK IGNAR VARIABLE DOMAIN
(-)
Human (Homo sapiens) [TaxId: 9606] (85)
1T2JA:CRYSTAL STRUCTURE OF A HUMAN VH DOMAIN
1WT5C:; D:THE CRYSTAL STRUCTURE OF A HUMANIZED ANTIBODY FV 528
2A9MH:; I:STRUCTURAL ANALYSIS OF A TIGHT-BINDING FLUORESCEIN-SCFV; APO FORM
2AGJL:1-107CRYSTAL STRUCTURE OF A GLYCOSYLATED FAB FROM AN IGM CRYOGLOBULIN WITH PROPERTIES OF A NATURAL PROTEOLYTIC ANTIBODY
2BX5A:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:; M:; N:; O:IS FR1 THE ANTIBODY'S ACHILLIES HEEL
2D7TL:CRYSTAL STRUCTURE OF HUMAN ANTI POLYHYDROXYBUTYRATE ANTIBODY FV
2EIZA:CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV MUTANT(HW47Y)-HEN LYSOZYME COMPLEX
2EKSA:CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV-HEN LYSOZYME COMPLEX
2HP4A:; B:COMPUTATIONAL DESIGN AND CRYSTAL STRUCTURE OF AN ENHANCED AFFINITY MUTANT HUMAN CD8-ALPHA-ALPHA CO-RECEPTOR
2J12B:AD37 FIBRE HEAD IN COMPLEX WITH CAR D1
2J1KA:; B:; G:; J:; K:; O:; P:; T:; V:; X:; Y:; Z:CAV-2 FIBRE HEAD IN COMPLEX WITH CAR D1
2KQMA:; B:SOLUTION STRUCTURE OF THE KI O18/O8 Y87H IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN
2KQNA:; B:SOLUTION STRUCTURE OF THE AL-09 H87Y IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN
2PYFB:1-113CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY UNBOUND TCR CLONE 5-1
2Q1EA:; B:; C:; D:ALTERED DIMER INTERFACE DECREASES STABILITY IN AN AMYLOIDOGENIC KAPPA1 BENCE JONES PROTEIN.
2Q20A:; B:STRUCTURE OF THE GERMLINE VK1 O18/O8 LIGHT CHAIN VARIABLE DOMAIN HOMODIMER
2UZIH:; L:CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV COMPLEX
2VH5H:; L:CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV (DISULFIDE FREE MUTANT) COMPLEX
2VYRE:; F:; G:; H:; I:; J:; K:; L:STRUCTURE OF HUMAN MDM4 N-TERMINAL DOMAIN BOUND TO A SINGLE DOMAIN ANTIBODY
2W0KA:; B:CRYSTAL STRUCTURE OF THE RECOMBINANT VARIABLE DOMAIN 6JAL2
2W0LA:; B:; C:; D:CRYSTAL STRUCTURE OF THE MUTANT H8P FROM THE RECOMBINANT VARIABLE DOMAIN 6JAL2
2WBWB:AD37 FIBRE HEAD IN COMPLEX WITH CAR D1 AND SIALIC ACID
2X44D:STRUCTURE OF A STRAND-SWAPPED DIMERIC FORM OF CTLA-4
2XTJB:THE CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH 1D05 FAB
2YBRA:; D:; G:CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN
2YC1A:; D:CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN
2YSSA:CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV MUTANT(HQ39KW47Y)-HEN LYSOZYME COMPLEX
3B5GA:; B:CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2
3B9VA:; B:; C:; D:CRYSTAL STRUCTURE OF AN AUTONOMOUS VH DOMAIN
3BDXA:; B:; C:CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2
3BQUA:1-107CRYSTAL STRUCTURE OF THE 2F5 FAB'-3H6 FAB COMPLEX
3BX7C:ENGINEERED HUMAN LIPOCALIN 2 (LCN2) IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HUMAN CTLA-4
3CDCA:; B:KI O18/O8 N34I/Y87H IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN
3CDFA:; D:; E:; F:; B:; C:KI O18/O8 Y87H IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN
3CDYA:; B:AL-09 H87Y, IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN
3DVFA:STRUCTURE OF AMYLOIDOGENIC KAPPA 1 BENCE JONES PROTEIN
3DVIA:CRYSTAL STRUCTURE OF KAPPA 1 AMYLOIDOGENIC LIGHT CHAIN VARIABLE DOMAIN
3DX9A:2-125; C:2-125CRYSTAL STRUCTURE OF THE DM1 TCR AT 2.75A
3EYQC:1-108CRYSTAL STRUCTURE OF MJ5 FAB, A GERMLINE ANTIBODY VARIANT OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
3F12A:1-108; C:1-108GERMLINE V-GENES SCULPT THE BINDING SITE OF A FAMILY OF ANTIBODIES NEUTRALIZING HUMAN CYTOMEGALOVIRUS
3GSNB:2-116CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
3H42L:1-112CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH FAB FROM LDLR COMPETITIVE ANTIBODY
3LRGA:; B:STRUCTURE OF ANTI-HUNTINGTIN VL DOMAIN
3LRHO:STRUCTURE OF ANTI-HUNTINGTIN VL DOMAIN IN COMPLEX WITH HUNTINGTIN PEPTIDE
3MLWL:1-107; M:1-107CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
3OSKA:; B:CRYSTAL STRUCTURE OF HUMAN CTLA-4 APO HOMODIMER
3P9WB:; D:; F:; H:CRYSTAL STRUCTURE OF AN ENGINEERED HUMAN AUTONOMOUS VH DOMAIN IN COMPLEX WITH VEGF
3Q6FA:2-107; C:2-107; E:2-107; G:2-107; I:2-107; K:2-107CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
3QCTL:1-107CRYSTAL STRUCTURE OF THE HUMANIZED APO LT3015 ANTI-LYSOPHOSPHATIDIC ACID ANTIBODY FAB FRAGMENT
3QCUL:1-107; M:1-107CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (14:0)
3QCVL:1-107; M:1-107CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2)
3QDGD:1-110THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
3QDJD:1-110THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QEGL:1-107CRYSTAL STRUCTURE OF HUMAN N12-I2 FAB, AN ADCC AND NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY
3QEUA:1-110; D:0-110THE CRYSTAL STRUCTURE OF TCR DMF5
3QH3A:1-111; C:1-111THE CRYSTAL STRUCTURE OF TCR A6
3REVB:3-115CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20
3RRQA:CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN PD-1
3SDYL:1-107CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8020 BOUND TO THE INFLUENZA A H3 HEMAGGLUTININ
3SO3B:1-106ASTRUCTURES OF FAB-PROTEASE COMPLEXES REVEAL A HIGHLY SPECIFIC NON-CANONICAL MECHANISM OF INHIBITION.
3U79A:; B:; C:; D:; E:; F:; G:; H:AL-103 Y32F Y96F
3U7AA:AL-09 Y32F Y96F
3UPAA:; B:A GENERAL STRATEGY FOR THE GENERATION OF HUMAN ANTIBODY VARIABLE DOMAINS WITH INCREASED AGGREGATION RESISTANCE
3UPCA:; B:; C:; D:; E:; F:; G:; H:; I:; J:A GENERAL STRATEGY FOR THE GENERATION OF HUMAN ANTIBODY VARIABLE DOMAINS WITH INCREASED AGGREGATION RESISTANCE
3ZHDA:; B:THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 8-4 SCAFFOLD.
3ZHKA:THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 2X1 SCAFFOLD
3ZHLA:THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 8-14 SCAFFOLD
4AIXA:; B:; C:; D:CRYSTALLOGRAPHIC STRUCTURE OF AN AMYLOIDOGENIC VARIANT, 3RC34Y, OF THE GERMINAL LINE LAMBDA 3
4AJ0A:; B:; C:; D:CRYSTALLOGRAPHIC STRUCTURE OF AN AMYLOIDOGENIC VARIANT, 3RCW, OF THE GERMINAL LINE LAMBDA 3
4AM0B:1-107; D:1-107; F:1-107; L:1-107STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
4DN3L:1-108CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888
4FQLL:1-107INFLUENZA B HA ANTIBODY (FAB) CR8033
4FQQA:3-108; C:3-108; E:3-108; L:3-108CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB
4GKZA:0-115; B:2-114HA1.7, A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ
4GRMA:2-117; C:1-117THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
4HWEL:1-104CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
4JDVB:2-103; L:1-103CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF NIH45-46 FAB
4JFHD:1-110HIGH AFFINITY ALPHA24-BETA17 T CELL RECEPTOR FOR A2 HLA-MELANOMA PEPTIDE COMPLEX
4JM2C:1-109CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
4K07A:; B:; C:; D:; E:; F:; G:; H:; I:; J:CRYSTAL STRUCTURE OF THE AMYLOID-FORMING IMMUNOGLOBULIN AL-103 CIS-PROLINE 95 MUTANT
4K3GA:; B:IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATING PROTEIN
4K3HA:; B:; C:; D:; E:; F:; G:; H:IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN
4KFZC:; D:CRYSTAL STRUCTURE OF LMO2 AND ANTI-LMO2 VH COMPLEX
4MWFB:3-107; L:2-107STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
(-)
Human herpesvirus 1 [TaxId: 10299] (1)
3U82A:BINDING OF HERPES SIMPLEX VIRUS GLYCOPROTEIN D TO NECTIN-1 EXPLOITS HOST CELL ADHESION
(-)
Human herpesvirus 2 [TaxId: 10315] (1)
3W9EC:STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB COMPLEX WITH HSV-2 GD
(-)
Llama (Lama glama) [TaxId: 9844] (62)
1SHMA:; B:; D:; E:CONVERGENT SOLUTIONS TO VHH DOMAIN STABILIZATION FROM NATURAL AND IN VITRO EVOLUTION
1SJXA:THREE-DIMENSIONAL STRUCTURE OF A LLAMA VHH DOMAIN OE7 BINDING THE CELL WALL PROTEIN MALF1
1U0QA:; B:STRUCTURE OF A LLAMA VHH DOMAIN RAISED AGAINST A CARBAZOLE MOLECULE
2BSED:; E:; F:STRUCTURE OF LACTOCOCCAL BACTERIOPHAGE P2 RECEPTOR BINDING PROTEIN IN COMPLEX WITH A LLAMA VHH DOMAIN
2WZPD:; E:; F:; J:; K:; L:STRUCTURES OF LACTOCOCCAL PHAGE P2 BASEPLATE SHED LIGHT ON A NOVEL MECHANISM OF HOST ATTACHMENT AND ACTIVATION IN SIPHOVIRIDAE
2X1OA:; B:GELSOLIN NANOBODY
2X1PA:; B:; C:; D:GELSOLIN NANOBODY
2X1QA:; B:GELSOLIN NANOBODY
2XA3A:CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING LLAMA VHH D7 AND ITS MODE OF HIV-1 GP120 INTERACTION
3CFIC:; F:; I:; L:NANOBODY-AIDED STRUCTURE DETERMINATION OF THE EPSI:EPSJ PSEUDOPILIN HETERDIMER FROM VIBRIO VULNIFICUS
3EZJB:; D:; F:; H:CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF THE SECRETIN GSPD FROM ETEC DETERMINED WITH THE ASSISTANCE OF A NANOBODY
3K74B:DISRUPTION OF PROTEIN DYNAMICS BY AN ALLOSTERIC EFFECTOR ANTIBODY
3K7UA:STRUCTURE OF ESSENTIAL PROTEIN FROM TRYPANOSOMA BRUCEI
3K80A:; B:STRUCTURE OF ESSENTIAL PROTEIN FROM TRYPANOSOMA BRUCEI
3QXTA:; B:STRUCTURE OF AN ANTI-METHOTREXATE CDR1-3 GRAFT VHH ANTIBODY IN COMPLEX WITH METHOTREXATE
3QXUA:; B:; C:; D:FREE STRUCTURE OF AN ANTI-METHOTREXATE CDR1-3 GRAFT VHH ANTIBODY
3QXVA:; D:; E:; B:; C:STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY IN COMPLEX WITH METHOTREXATE
3QXWA:; B:; C:; D:; E:FREE STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY
3R0MA:; B:CRYSTAL STRUCTURE OF ANTI-HIV LLAMA VHH ANTIBODY A12
3RJQB:CRYSTAL STRUCTURE OF ANTI-HIV LLAMA VHH ANTIBODY A12 IN COMPLEX WITH C186 GP120
3STBA:; B:A COMPLEX OF TWO EDITOSOME PROTEINS AND TWO NANOBODIES
3ZKQD:BACE2 XAPERONE COMPLEX
3ZKSD:BACE2 XAPERONE COMPLEX WITH INHIBITOR
3ZKXB:; C:TERNARY BACE2 XAPERONE COMPLEX
3ZLQC:; D:BACE2 XAPERONE COMPLEX
4AQ1B:; D:STRUCTURE OF THE SBSB S-LAYER PROTEIN OF GEOBACILLUS STEAROTHERMOPHILUS PV72P2 IN COMPLEX WITH NANOBODY KB6
4B41A:; B:CRYSTAL STRUCTURE OF AN AMYLOID-BETA BINDING SINGLE CHAIN ANTIBODY G7
4B50A:CRYSTAL STRUCTURE OF THE HIV-1 GP41 MPER-SPECIFIC LLAMA VHH 2H10
4B5EA:; B:CRYSTAL STRUCTURE OF AN AMYLOID-BETA BINDING SINGLE CHAIN ANTIBODY PS2-8
4BELD:; E:BACE2 XAPERONE COMPLEX
4BFBD:; E:BACE2 XAPERONE COMPLEX
4CDGC:; D:CRYSTAL STRUCTURE OF THE BLOOM'S SYNDROME HELICASE BLM IN COMPLEX WITH NANOBODY
4DK3A:; B:STRUCTURE OF EDITOSOME PROTEIN
4DK6A:; B:STRUCTURE OF EDITOSOME PROTEIN
4DKAA:; B:STRUCTURE OF EDITOSOME PROTEIN
4EIGB:CA1698 CAMEL ANTIBODY FRAGMENT IN COMPLEX WITH DHFR
4EIZC:; D:STRUCTURE OF NB113 BOUND TO APODHFR
4EJ1C:; D:BINDING OF NB113 CAMELID ANTIBODY FRAGMENT WITH THE BINARY DHFR:FOLATE COMPLEX
4FHBD:ENHANCING DHFR CATALYSIS BY BINDING OF AN ALLOSTERIC REGULATOR NANOBODY (NB179)
4GFTB:MALARIA INVASION MACHINERY PROTEIN-NANOBODY COMPLEX
4HEME:; F:; G:LLAMA VHH-02 BINDER OF ORF49 (RBP) FROM LACTOCOCCAL PHAGE TP901-1
4HEPG:COMPLEX OF LACTOCOCCAL PHAGE TP901-1 WITH A LLAMA VHH (VHH17) BINDER (NANOBODY)
4I13B:NANOBODY CA1697 BINDING TO THE DHFR.FOLATE BINARY COMPLEX
4I1NB:R104A-CA1697 NANOBODY BINDING TO THE BINARY DHFR.FOLATE COMPLEX
4IDLA:LOW MELTING TEMPERATURE ANTI-CHOLERA TOXIN LLAMA VHH DOMAIN
4IOSD:; E:; F:; G:STRUCTURE OF PHAGE TP901-1 RBP (ORF49) IN COMPLEX WITH NANOBODY 11.
4KMLB:PROBING THE N-TERMINAL BETA-SHEET CONVERSION IN THE CRYSTAL STRUCTURE OF THE FULL-LENGTH HUMAN PRION PROTEIN BOUND TO A NANOBODY
4KRLB:NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR, PH 6.0
4KRMB:; D:; F:; H:; J:; L:NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR, PH 3.5
4KRNA:NANOBODY/VHH DOMAIN EGA1
4KRPB:NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
4LDEB:STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO BI167107 AND AN ENGINEERED NANOBODY
4LDLB:STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO HYDROXYBENZYLISOPROTERENOL AND AN ENGINEERED NANOBODY
4N9OB:PROBING THE N-TERMINAL BETA-SHEET CONVERSION IN THE CRYSTAL STRUCTURE OF THE HUMAN PRION PROTEIN BOUND TO A NANOBODY
4NBXB:CRYSTAL STRUCTURE OF CLOSTRIDIUM DIFFICILE TOXIN A FRAGMENT TCDA-A1 BOUND TO A20.1 VHH
4NBYB:; C:CRYSTAL STRUCTURE OF TCDA-A2 BOUND TO TWO MOLECULES OF A20.1 VHH
4NC0B:CRYSTAL STRUCTURE OF TCDA-A2 BOUND TO A26.8 VHH
4NC1C:; D:; E:; F:CRYSTAL STRUCTURE OF TCDA-A2 BOUND TO A20.1 VHH AND A26.8 VHH
4OCLC:; F:CRYSTAL STRUCTURE OF THE RPN8-RPN11 MPN DOMAIN HETERODIMER, CRYSTAL FORM IA
4OCMC:; F:CRYSTAL STRUCTURE OF THE RPN8-RPN11 MPN DOMAIN HETERODIMER, CRYSTAL FORM IB
4OCNC:; F:CRYSTAL STRUCTURE OF THE RPN8-RPN11 MPN DOMAIN HETERODIMER, CRYSTAL FORM II
4ORZC:HIV-1 NEF PROTEIN IN COMPLEX WITH SINGLE DOMAIN ANTIBODY SDAB19 AND AN ENGINEERED HCK SH3 DOMAIN
(-)
Llama glama [TaxId: 9844] (1)
4GRWE:; F:; G:; H:; J:STRUCTURE OF A COMPLEX OF HUMAN IL-23 WITH 3 NANOBODIES (LLAMA VHHS)
(-)
Macaca mulatta [TaxId: 9541] (1)
2Q3AA:; B:CRYSTAL STRUCTURE OF RHESUS MACAQUE CD8 ALPHA-ALPHA HOMODIMER
(-)
Mouse (Mus musculus) [TaxId: 10090] (112)
1T2QL:2-114THE CRYSTAL STRUCTURE OF AN NNA7 FAB THAT RECOGNIZES AN N-TYPE BLOOD GROUP ANTIGEN
1UYWL:1-107; N:1-107CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
1WZ1H:CRYSTAL STRUCTURE OF THE FV FRAGMENT COMPLEXED WITH DANSYL-LYSINE
2A1WL:1-113; M:1-113ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM I
2A77L:1-113ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM II
2ADFL:1-106CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3, AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN
2AI0L:1-113; M:1-113; N:1-113; O:1-113ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM III
2AQ1A:; C:; E:; G:CRYSTAL STRUCTURE OF T-CELL RECEPTOR V BETA DOMAIN VARIANT COMPLEXED WITH SUPERANTIGEN SEC3 MUTANT
2AQ3C:; E:; G:CRYSTAL STRUCTURE OF T-CELL RECEPTOR V BETA DOMAIN VARIANT COMPLEXED WITH SUPERANTIGEN SEC3
2BVEA:; B:STRUCTURE OF THE N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH 2-PHENYL-PROP5AC
2CJUH:; L:CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5-OXAZOLONE NQ16-113.8 SCFV IN COMPLEX WITH PHOXGABA
2D03L:2-114CRYSTAL STRUCTURE OF THE G91S MUTANT OF THE NNA7 FAB
2DDQL:1-112CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A R310 ANTIBODY COMPLEXED WITH (R)-HNE-HISTIDINE ADDUCT
2DQTL:1-107HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG
2DQUL:1-107CRYSTAL FORM II: HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG
2DTML:1-107THERMODYNAMIC AND STRUCTURAL ANALYSES OF HYDROLYTIC MECHANISM BY CATALYTIC ANTIBODIES
2E27H:CRYSTAL STRUCTURE OF FV FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY COMPLEXED WITH ABC-RING OF CIGUATOXIN
2E7LA:; B:; C:; D:STRUCTURE OF A HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
2G60L:1-108STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN
2GJZA:1-108; L:1-108STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1)
2GK0A:1-108; L:1-108STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2
2GSGB:; D:CRYSTAL STRUCTURE OF THE FV FRAGMENT OF A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE
2HKHL:1-112CRYSTAL STRUCTURE OF THE FAB M75
2ICWL:CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR, SUPERANTIGEN, AND PEPTIDE-MHC CLASS II MOLECULE
2IPTL:1-106APFA1 FAB FRAGMENT
2IQ9L:1-106APFA2 FAB FRAGMENT, TRICLINIC APO FORM
2IQAA:1-106A; L:1-106APFA2 FAB FRAGMENT, MONOCLINIC APO FORM
2NTFA:1-108; L:1-108CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N-ACYL-L-HOMOSERINE LACTONE ANALOG
2O5XL:1-107CRYSTAL STRUCTURE OF 1E9 LEUH47TRP/ARGH100TRP, AN ENGINEERED DIELS-ALDERASE FAB WITH NM STEROID-BINDING AFFINITY
2O5YL:1-107CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX
2O5ZL:1-107CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB 5-BETA-ANDROSTANE-3,17-DIONE COMPLEX
2OI9B:; C:STRUCTURE OF THE 2C/LD/QL9 ALLOGENEIC COMPLEX
2OP4L:1-108CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9
2ORBL:1-107; M:1-107THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT
2P1YE:3-116; G:3-1161.B2.D9, A BISPECIFIC ALPHA/BETA TCR
2PXYA:; B:CRYSTAL STRUCTURES OF IMMUNE RECEPTOR COMPLEXES
2R0WL:1-106APFA2 FAB COMPLEXED WITH ABETA1-8
2R0ZL:1-106APFA1 FAB COMPLEXED WITH GRIPI PEPTIDE FRAGMENT
2UUDK:; L:CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5-OXAZOLONE NQ10-1.12 SCFV IN COMPLEX WITH THE HAPTEN
2UYLA:1-112; M:1-112; V:1-112; X:1-112CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2VQ1A:1-107; E:1-107ANTI TRIMERIC LEWIS X FAB54-5C10-A
2Z31A:; B:CRYSTAL STRUCTURE OF IMMUNE RECEPTOR COMPLEX
2Z35A:; B:CRYSTAL STRUCTURE OF IMMUNE RECEPTOR
2Z4QA:1-112CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
3AB0B:; E:CRYSTAL STRUCTURE OF COMPLEX OF THE BACILLUS ANTHRACIS MAJOR SPORE SURFACE PROTEIN BCLA WITH SCFV ANTIBODY FRAGMENT
3BD3A:; B:CRYSTAL STRUCTURE OF SINGLE DOMAIN VL OF AN ANTI-DNA BINDING ANTIBODY 3D8 SCFV AND ITS ACTIVE SITE REVEALED BY COMPLEX STRUCTURES OF A SMALL MOLECULE AND METALS
3BD4A:; B:CRYSTAL STRUCTURE OF SINGLE DOMAIN VL OF AN ANTI-DNA BINDING ANTIBODY 3D8 SCFV AND ITS ACTIVE SITE REVEALED BY COMPLEX STRUCTURES OF A SMALL MOLECULE AND METALS
3BD5A:; B:CRYSTAL STRUCTURE OF SINGLE DOMAIN VL OF AN ANTI-DNA BINDING ANTIBODY 3D8 SCFV AND ITS ACTIVE SITE REVEALED BY COMPLEX STRUCTURES OF A SMALL MOLECULE AND METALS
3BYTA:; C:; E:; G:A COMPLEX BETWEEN A VARIANT OF STAPHYLOCOCCAL ENTEROTOXIN C3 AND THE VARIABLE DOMAIN OF THE MURINE T CELL RECEPTOR BETA CHAIN 8.2
3BYYA:MANIPULATING THE COUPLED FOLDING AND BINDING PROCESS DRIVES AFFINITY MATURATION IN A PROTEIN-PROTEIN COMPLEX
3BZDA:MANIPULATING THE COUPLED FOLDING AND BINDING PROCESS DRIVES AFFINITY MATURATION IN A PROTEIN-PROTEIN COMPLEX
3CLEL:1-107HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
3CLFL:1-107HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
3DURA:; B:; C:; D:CRYSTAL STRUCTURE OF SAG173-04
3DUSA:; B:; C:; D:CRYSTAL STRUCTURE OF SAG506-01, ORTHORHOMBIC, TWINNED, CRYSTAL 1
3DUUA:; B:; C:; D:CRYSTAL STRUCTURE OF SAG506-01, ORTHORHOMBIC, TWINNED, CRYSTAL 2
3DV4A:; B:CRYSTAL STRUCTURE OF SAG506-01, TETRAGONAL, CRYSTAL 1
3DV6A:; B:CRYSTAL STRUCTURE OF SAG506-01, TETRAGONAL, CRYSTAL 2
3E3Qa:; C:; E:; F:; J:; N:; S:; W:STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
3EHBC:; D:A D-PATHWAY MUTATION DECOUPLES THE PARACOCCUS DENITRIFICANS CYTOCHROME C OXIDASE BY ALTERING THE SIDE CHAIN ORIENTATION OF A DISTANT, CONSERVED GLUTAMATE
3EO0A:1-108; C:1-108STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008
3EO1A:1-107; D:1-107; G:1-107; J:1-107STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
3FO0L:1-112CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (WILD-TYPE)
3FO1A:1-112; L:1-112CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
3FO2A:1-112; L:1-112CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
3FO9A:1-107; L:1-107CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB' IN COMPLEX WITH HAPTEN 1,3-DIKETONE
3G5XA:1-107; C:1-107ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
3GNML:1-112THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT
3HB3C:; D:HIGH RESOLUTION CRYSTAL STRUCTURE OF PARACOCCUS DENITRIFICANS CYTOCHROME C OXIDASE
3IETA:2-107; C:1-107CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN
3IF1A:2-112; C:2-112CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC
3MC0A:; C:CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN G (SEG) IN COMPLEX WITH A MOUSE T-CELL RECEPTOR BETA CHAIN
3MCKA:1-112; L:1-112CRYSTAL STRUCTURE OF ANTI-BETA-AMYLOID ANTIBODY C705
3NN8A:; B:; C:; D:; E:; F:; G:; H:CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
3NZ8B:1-107; L:1-107CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
3O2VL:1-107CRYSTAL STRUCTURE OF 1E9 PHEL89SER/LEUH47TRP/METH100BPHE, AN ENGINEERED DIELS-ALDERASE FAB WITH MODIFIED SPECIFICITY AND CATALYTIC ACTIVITY
3O2WL:1-107CRYSTAL STRUCTURE OF THE 1E9 PHEL89SER/LEUH47TRP/METH100BPHE FAB IN COMPLEX WITH A 39A11 TRANSITION STATE ANALOG
3O8XD:2-112RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR
3O9WD:2-112RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR
3OWEA:; C:; E:; G:; I:; K:; M:; O:CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN G (SEG) IN COMPLEX WITH A HIGH AFFINITY MUTANT MOUSE T-CELL RECEPTOR CHAIN
3QA3A:1-120; C:1-120; F:1-120; J:1-120CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3QG7L:1-107STRUCTURAL BASIS FOR LIGAND RECOGNITION AND DISCRIMINATION OF A QUORUM QUENCHING ANTIBODY
3QUXD:2-112STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX
3QUYD:2-112STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1'-INKT TCR COMPLEX
3QUZD:2-112STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX
3R4DA:1-107; C:1-107CRYSTAL STRUCTURE OF MOUSE CORONAVIRUS RECEPTOR-BINDING DOMAIN COMPLEXED WITH ITS MURINE RECEPTOR
3RNKA:CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MOUSE PD-1 MUTANT AND PD-L2 IGV DOMAIN
3RNQA:CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EXTRACELLULAR DOMAINS OF MOUSE PD-1 MUTANT AND PD-L2
3TA3D:2-112STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2-INKT TCR COMPLEX
3TVMD:2-112; H:1-112STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
3UTZA:2-112; D:2-112; E:2-112ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL
3V4PL:1-113; N:1-113CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
3V4VL:1-113; N:1-113CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
4A6YL:1-110CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3-NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
4AEIL:1-112; M:1-112; N:1-112CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
4ALAL:1-107STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
4AMKL:2-110FAB FRAGMENT OF ANTIPORPHRIN ANTIBODY 13G10
4AT6B:1-110; D:1-110; F:1-110; I:1-110; K:1-110; L:1-110; N:1-110; P:1-110FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
4F37K:1-112; L:1-112STRUCTURE OF THE TETHERED N-TERMINUS OF ALZHEIMER'S DISEASE A PEPTIDE
4FFYH:; L:CRYSTAL STRUCTURE OF DENV1-E111 SINGLE CHAIN VARIABLE FRAGMENT BOUND TO DENV-1 DIII, STRAIN 16007.
4HC1L:1-107; N:1-107CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3
4HDIA:1-112; L:1-112CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS
4HXBL:1-107CRYSTAL STRUCTURE OF 6B9 FAB
4HZLB:1-113; L:1-113NEUTRALIZING ANTIBODY MAB#8 IN COMPLEX WITH THE EPITOPE II OF HCV E2 ENVELOPE PROTEIN
4IRSD:2-112STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX
4KVCL:1-1072H2 FAB FRAGMENT OF IMMATURE DENGUE VIRUS
4LARH:CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE
4LASH:CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE
4M7JL:1-107CRYSTAL STRUCTURE OF S25-26 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO TRISACCHARIDE
4M7ZC:1-107; L:1-107UNLIGANDED 1 CRYSTAL STRUCTURE OF S25-26 FAB
4M93C:1-107; L:1-107UNLIGANDED 2 CRYSTAL STRUCTURE OF S25-26 FAB
4MA1C:1-107; F:1-107; L:1-107UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (7)
2APBA:CRYSTAL STRUCTURE OF THE S54N VARIANT OF MURINE T CELL RECEPTOR VBETA 8.2 DOMAIN
2APFA:CRYSTAL STRUCTURE OF THE A52V/S54N/K66E VARIANT OF THE MURINE T CELL RECEPTOR V BETA 8.2 DOMAIN
2APTA:; B:CRYSTAL STRUCTURE OF THE G17E/S54N/K66E/Q72H/E80V/L81S/T87S/G96V VARIANT OF THE MURINE T CELL RECEPTOR V BETA 8.2 DOMAIN
2APVA:CRYSTAL STRUCTURE OF THE G17E/A52V/S54N/Q72H/E80V/L81S/T87S/G96V VARIANT OF THE MURINE T CELL RECEPTOR V BETA 8.2 DOMAIN
2APWA:CRYSTAL STRUCTURE OF THE G17E/A52V/S54N/K66E/E80V/L81S/T87S/G96V VARIANT OF THE MURINE T CELL RECEPTOR V BETA 8.2 DOMAIN
2APXA:CRYSTAL STRUCTURE OF THE G17E/A52V/S54N/K66E/Q72H/E80V/L81S/T87S/G96V VARIANT OF THE MURINE T CELL RECEPTOR V BETA 8.2 DOMAIN
3R8BB:; H:; J:; L:; N:; P:; D:; F:CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B IN COMPLEX WITH AN AFFINITY MATURED MOUSE TCR VBETA8.2 PROTEIN, G5-8
(-)
Nurse shark (Ginglymostoma cirratum) [TaxId: 7801] (4)
2I24N:CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR PBLA8 VARIABLE DOMAIN
2I25N:; O:CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR PBLA8 VARIABLE DOMAIN IN COMPLEX WITH LYSOZYME
2I26O:; P:CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR ANCESTRAL VARIABLE DOMAIN IN COMPLEX WITH LYSOZYME
2I27N:; O:CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR ANCESTRAL VARIABLE DOMAIN
(-)
Ornithorhynchus anatinus [TaxId: 9258] (1)
4N8PA:CRYSTAL STRUCTURE OF A STRAND SWAPPED CTLA-4 FROM DUCKBILL PLATYPUS [PSI-NYSGRC-012711]
(-)
Rat (Rattus rattus) [TaxId: 10117] (1)
3B9KC:1-107; L:1-107CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
(-)
Spotted wobbegong (Orectolobus maculatus) [TaxId: 168098] (5)
2COQA:STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
2YWYA:; B:; C:; D:STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
2YWZA:STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
2Z8VC:; D:STRUCTURE OF AN IGNAR-AMA1 COMPLEX
2Z8WC:; D:STRUCTURE OF AN IGNAR-AMA1 COMPLEX
(-)
Vicugna pacos [TaxId: 30538] (5)
2XT1B:CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C-TERMINAL DOMAIN (146-231) IN COMPLEX WITH A CAMELID VHH.
2XV6B:; D:CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C-TERMINAL DOMAIN (146-220) IN COMPLEX WITH A CAMELID VHH.
2XXCB:CRYSTAL STRUCTURE OF A CAMELID VHH RAISED AGAINST THE HIV-1 CAPSID PROTEIN C-TERMINAL DOMAIN.
2XXMB:CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C-TERMINAL DOMAIN IN COMPLEX WITH A CAMELID VHH AND THE CAI PEPTIDE.
4JVPA:; B:THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 ALPACA NANOBODY D03
(-)
Protein domain: B- and T-lymphocyte attenuator CD272 (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
2AW2A:34-137; X:CRYSTAL STRUCTURE OF THE HUMAN BTLA-HVEM COMPLEX
(-)
Protein domain: Biliary glycoprotein C (CD66a, CEACAM1A[1,4]), N-terminal domain (1)
(-)
Mouse (Mus musculus) [TaxId: 10090] (1)
1L6ZA:1-107CRYSTAL STRUCTURE OF MURINE CEACAM1A[1,4]: A CORONAVIRUS RECEPTOR AND CELL ADHESION MOLECULE IN THE CEA FAMILY
(-)
Protein domain: Camelid IG heavy chain variable domain, VHh (28)
(-)
Camel (Camelus dromedarius) [TaxId: 9838] (19)
1BZQK:; L:; M:; N:COMPLEX OF A DROMEDARY SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A
1F2XK:; L:STRUCTURE OF THE SINGLE-DOMAIN CAMELID ANTIBODY CAB-CA05
1G6VK:COMPLEX OF THE CAMELID HEAVY-CHAIN ANTIBODY FRAGMENT CAB-CA05 WITH BOVINE CARBONIC ANHYDRASE
1JTOA:; B:DEGENERATE INTERFACES IN ANTIGEN-ANTIBODY COMPLEXES
1JTPA:; B:DEGENERATE INTERFACES IN ANTIGEN-ANTIBODY COMPLEXES
1JTTA:DEGENERATE INTERFACES IN ANTIGEN-ANTIBODY COMPLEXES
1KXQE:; F:; G:; H:CAMELID VHH DOMAIN IN COMPLEX WITH PORCINE PANCREATIC ALPHA-AMYLASE
1KXTB:; D:; F:CAMELID VHH DOMAINS IN COMPLEX WITH PORCINE PANCREATIC ALPHA-AMYLASE
1KXVC:; D:CAMELID VHH DOMAINS IN COMPLEX WITH PORCINE PANCREATIC ALPHA-AMYLASE
1MELA:; B:CRYSTAL STRUCTURE OF A CAMEL SINGLE-DOMAIN VH ANTIBODY FRAGMENT IN COMPLEX WITH LYSOZYME
1MVFA:; B:MAZE ADDICTION ANTIDOTE
1OP9A:COMPLEX OF HUMAN LYSOZYME WITH CAMELID VHH HL6 ANTIBODY FRAGMENT
1RI8A:2-125CRYSTAL STRUCTURE OF THE CAMELID SINGLE DOMAIN ANTIBODY 1D2L19 IN COMPLEX WITH HEN EGG WHITE LYSOZYME
1RJCA:2-127CRYSTAL STRUCTURE OF THE CAMELID SINGLE DOMAIN ANTIBODY CAB-LYS2 IN COMPLEX WITH HEN EGG WHITE LYSOZYME
1XFPA:CRYSTAL STRUCTURE OF THE CDR2 GERMLINE REVERSION MUTANT OF CAB-LYS3 IN COMPLEX WITH HEN EGG WHITE LYSOZYME
1ZMYA:1-133CABBCII-10 VHH FRAMEWORK WITH CDR LOOPS OF CABLYS3 GRAFTED ON IT AND IN COMPLEX WITH HEN EGG WHITE LYSOZYME
1ZV5A:2-120CRYSTAL STRUCTURE OF THE VARIABLE DOMAIN OF THE CAMELID HEAVY-CHAIN ANTIBODY D2-L29 IN COMPLEX WITH HEN EGG WHITE LYSOZYME
1ZVHA:2-124CRYSTAL STRUCTURE OF THE VHH DOMAIN D2-L24 IN COMPLEX WITH HEN EGG WHITE LYSOZYME
1ZVYA:2-125CRYSTAL STRUCTURE OF THE VHH D3-L11 IN COMPLEX WITH HEN EGG WHITE LYSOZYME
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1ZA3B:1-113; H:1-113THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
3BN9D:1-113; F:1-113CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
(-)
Llama (Lama glama) [TaxId: 9844] (7)
1G9EA:SOLUTION STRUCTURE AND RELAXATION MEASUREMENTS OF AN ANTIGEN-FREE HEAVY CHAIN VARIABLE DOMAIN (VHH) FROM LLAMA
1HCVA:LLAMA HEAVY CHAIN VARIABLE DOMAIN AGAINST ALPHA SUBUNIT OF HCG (HUMAN CHORIONIC GONADOTROPIN)
1I3UA:THREE-DIMENSIONAL STRUCTURE OF A LLAMA VHH DOMAIN COMPLEXED WITH THE DYE RR1
1I3VA:; B:THREE-DIMENSIONAL STRUCTURE OF A LAMA VHH DOMAIN UNLIGANDED
1IEHA:SOLUTION STRUCTURE OF A SOLUBLE SINGLE-DOMAIN ANTIBODY WITH HYDROPHOBIC RESIDUES TYPICAL OF A VL/VH INTERFACE
1QD0A:CAMELID HEAVY CHAIN VARIABLE DOMAINS PROVIDE EFFICIENT COMBINING SITES TO HAPTENS
1SJVA:THREE-DIMENSIONAL STRUCTURE OF A LLAMA VHH DOMAIN SWAPPING
(-)
Protein domain: CD2, first domain (9)
(-)
Human (Homo sapiens) [TaxId: 9606] (4)
1CDBA:STRUCTURE OF THE GLYCOSYLATED ADHESION DOMAIN OF HUMAN T LYMPHOCYTE GLYCOPROTEIN CD2
1GYAA:N-GLYCAN AND POLYPEPTIDE NMR SOLUTION STRUCTURES OF THE ADHESION DOMAIN OF HUMAN CD2
1HNFA:4-104CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE HUMAN CELL ADHESION MOLECULE CD2 AT 2.5 ANGSTROMS RESOLUTION
1QA9A:; C:STRUCTURE OF A HETEROPHILIC ADHESION COMPLEX BETWEEN THE HUMAN CD2 AND CD58(LFA-3) COUNTER-RECEPTORS
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (5)
1A64A:; B:ENGINEERING A MISFOLDED FORM OF RAT CD2
1A6PA:; B:ENGINEERING OF A MISFOLDED FORM OF CD2
1A7BA:; C:; D:; B:ENGINEERING A MISFOLDED FORM OF CD2
1CDCA:; B:CD2, N-TERMINAL DOMAIN (1-99), TRUNCATED FORM
1HNGA:2-99; B:2-99CRYSTAL STRUCTURE AT 2.8 ANGSTROMS RESOLUTION OF A SOLUBLE FORM OF THE CELL ADHESION MOLECULE CD2
(-)
Protein domain: CD2-binding domain of CD58, N-terminal domain (3)
(-)
Human (Homo sapiens) [TaxId: 9606] (3)
1CCZA:1-93CRYSTAL STRUCTURE OF THE CD2-BINDING DOMAIN OF CD58 (LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN 3) AT 1.8-A RESOLUTION
1CI5A:1-95GLYCAN-FREE MUTANT ADHESION DOMAIN OF HUMAN CD58 (LFA-3)
1QA9B:; D:STRUCTURE OF A HETEROPHILIC ADHESION COMPLEX BETWEEN THE HUMAN CD2 AND CD58(LFA-3) COUNTER-RECEPTORS
(-)
Protein domain: CD28 (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1YJDC:1-118CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)
(-)
Protein domain: CD4 V-set domains (31)
(-)
Human (Homo sapiens) [TaxId: 9606] (30)
1CDHA:1-97STRUCTURES OF AN HIV AND MHC BINDING FRAGMENT FROM HUMAN CD4 AS REFINED IN TWO CRYSTAL LATTICES
1CDIA:0-97STRUCTURES OF AN HIV AND MHC BINDING FRAGMENT FROM HUMAN CD4 AS REFINED IN TWO CRYSTAL LATTICES
1CDJA:1-97STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4
1CDUA:1-97STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4 MUTANT WITH PHE 43 REPLACED BY VAL
1CDYA:1-97STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4 MUTANT WITH GLY 47 REPLACED BY SER
1G9MC:1-97HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1G9NC:1-97HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1GC1C:1-97HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY
1JL4D:1-97CRYSTAL STRUCTURE OF THE HUMAN CD4 N-TERMINAL TWO DOMAIN FRAGMENT COMPLEXED TO A CLASS II MHC MOLECULE
1RZJC:1-97HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1RZKC:1-97HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1WIOA:1-97; A:179-291; B:1-97; B:179-291STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, TETRAGONAL CRYSTAL FORM
1WIPA:1-97; A:179-291; B:1-97; B:179-291STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, MONOCLINIC CRYSTAL FORM
1WIQA:1-97; A:179-291; B:1-97; B:179-291STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, TRIGONAL CRYSTAL FORM
2B4CC:1-97CRYSTAL STRUCTURE OF HIV-1 JR-FL GP120 CORE PROTEIN CONTAINING THE THIRD VARIABLE REGION (V3) COMPLEXED WITH CD4 AND THE X5 ANTIBODY
2NXYB:1001-1097HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NXZB:1001-1097HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T257S, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY0B:1001-1097HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, T257S, V275C, S334A, S375W, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY1B:1001-1097HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C, T257S, S334A, S375W, Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY2B:1001-1097HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T123C, T257S, S334A, S375W, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY3B:1001-1097HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E267C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY4B:1001-1097HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E268C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY5C:1001-1097HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY6B:1001-1097HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2QADB:1-97; F:1-97STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
3CD4A:1-97REFINEMENT AND ANALYSIS OF THE FIRST TWO DOMAINS OF HUMAN CD4
3JWDC:1000-1097; D:1001-1097STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY
3O2DA:1-97CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY
4H8WC:1-97CRYSTAL STRUCTURE OF NON-NEUTRALIZING AND ADCC-POTENT ANTIBODY N5-I5 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND SCD4.
4JM2F:1-97CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
(-)
Rat (Rattus rattus) [TaxId: 10117] (1)
1CIDA:1-105CRYSTAL STRUCTURE OF DOMAINS 3 & 4 OF RAT CD4 AND THEIR RELATIONSHIP TO THE NH2-TERMINAL DOMAINS
(-)
Protein domain: CD8 (10)
(-)
Human (Homo sapiens) [TaxId: 9606] (3)
1AKJD:; E:COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8
1CD8A:CRYSTAL STRUCTURE OF A SOLUBLE FORM OF THE HUMAN T CELL CO-RECEPTOR CD8 AT 2.6 ANGSTROMS RESOLUTION
3QZWG:; H:; I:; J:PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402
(-)
Mouse (Mus musculus) [TaxId: 10090] (5)
1BQHG:; H:; I:; K:MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
1NEZG:; H:THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION:IMPLICATIONS FOR MEMORY T CELL GENERATION, CO-RECEPTOR PREFERENCE AND AFFINITY
2ARJQ:; R:CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
2ATPA:; C:CRYSTAL STRUCTURE OF A CD8AB HETERODIMER
3B9KA:; E:CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
(-)
Mouse (Mus musculus), beta-chain [TaxId: 10090] (2)
2ATPB:1-115; D:CRYSTAL STRUCTURE OF A CD8AB HETERODIMER
3B9KB:; F:CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
(-)
Protein domain: CD80, N-terminal domain (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1DR9A:1-105CRYSTAL STRUCTURE OF A SOLUBLE FORM OF B7-1 (CD80)
1I8LA:1-105; B:1-105HUMAN B7-1/CTLA-4 CO-STIMULATORY COMPLEX
(-)
Protein domain: CD86 (b7-2), N-terminal domain (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1I85A:; B:CRYSTAL STRUCTURE OF THE CTLA-4/B7-2 COMPLEX
1NCNA:; B:THE RECEPTOR-BINDING DOMAIN OF HUMAN B7-2
(-)
Protein domain: Coxsackie virus and adenovirus receptor (Car), domain 1 (7)
(-)
Human (Homo sapiens) [TaxId: 9606] (7)
1EAJA:; B:DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN AT 1.35 ANGSTROM RESOLUTION
1F5WA:; B:DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN
1KACB:KNOB DOMAIN FROM ADENOVIRUS SEROTYPE 12 IN COMPLEX WITH DOMAIN 1 OF ITS CELLULAR RECEPTOR CAR
1P69B:STRUCTURAL BASIS FOR VARIATION IN ADENOVIRUS AFFINITY FOR THE CELLULAR RECEPTOR CAR (P417S MUTANT)
1P6AB:STRUCTURAL BASIS FOR VARIATION IN ASDENOVIRUS AFFINITY FOR THE CELLULAR RECEPTOR CAR (S489Y MUTANT)
1RSFA:NMR STRUCTURE OF MONOMERIC CAR D1 DOMAIN
2W9LA:; O:; P:; T:; V:; X:; Y:; Z:; B:; G:; J:; K:CANINE ADENOVIRUS TYPE 2 FIBRE HEAD IN COMPLEX WITH CAR DOMAIN D1 AND SIALIC ACID
(-)
Protein domain: HSV glycoprotein D (2)
(-)
Herpes simplex virus type 1 [TaxId: 10298] (2)
1JMAA:CRYSTAL STRUCTURE OF THE HERPES SIMPLEX VIRUS GLYCOPROTEIN D BOUND TO THE CELLULAR RECEPTOR HVEA/HVEM
1L2GA:; B:; C:; D:STRUCTURE OF A C-TERMINALLY TRUNCATED FORM OF GLYCOPROTEIN D FROM HSV-1
(-)
Protein domain: Immunoglobulin heavy chain variable domain, VH (658)
(-)
Chinese hamster (Cricetulus griseus) [TaxId: 10029] (1)
1NFDF:1-114; H:1-114AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
(-)
Engineered (including hybrid species) (68)
1AD0B:1-113; D:1-113FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7
1AD9B:1-113; H:1-113IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01
1B2WH:1-117COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY
1BVKB:; E:HUMANIZED ANTI-LYSOZYME FV COMPLEXED WITH LYSOZYME
1BVLA:; C:HUMANIZED ANTI-LYSOZYME FV
1FGVH:X-RAY STRUCTURES OF FRAGMENTS FROM BINDING AND NONBINDING VERSIONS OF A HUMANIZED ANTI-CD18 ANTIBODY: STRUCTURAL INDICATIONS OF THE KEY ROLE OF VH RESIDUES 59 TO 65
1FVCB:; D:X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
1FVDB:1-120; D:1-120X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
1FVEB:1-120; D:1-120X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
1GPOH:1-113; I:1-113CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
1I9RH:1-118; K:1-118; X:1-118STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
1IT9H:1-121CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT FROM A HUMANIZED VERSION OF THE ANTI-HUMAN FAS ANTIBODY HFE7A
1JPSH:1-117CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44
1JPTH:1-117CRYSTAL STRUCTURE OF FAB D3H44
1JV5B:ANTI-BLOOD GROUP A FV
1L7IH:1-113CRYSTAL STRUCTURE OF THE ANTI-ERBB2 FAB2C4
1MHPH:1-118; X:CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY
1N8ZB:1-120CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN HER2 COMPLEXED WITH HERCEPTIN FAB
1OHQA:; B:CRYSTAL STRUCTURE OF HEL4, A SOLUBLE HUMAN VH ANTIBODY DOMAIN RESISTANT TO AGGREGATION
1OL0A:; B:CRYSTAL STRUCTURE OF A CAMELISED HUMAN VH
1OM3H:1-115; K:1-115FAB 2G12 UNLIGANDED
1OP3H:1-115; M:1-115CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN
1OP5H:1-115; M:1-115CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN9GLCNAC2
1PG7H:1-117; I:1-117MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
1RJLB:1-120STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831
1S78D:1-113; F:1-113INSIGHTS INTO ERBB SIGNALING FROM THE STRUCTURE OF THE ERBB2-PERTUZUMAB COMPLEX
1T04B:1-118; D:1-118THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP
1T3FB:1-118THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB (HUZAF) IN P21 21 21 SPACE GROUP
1TJGH:1-113CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 7MER EPITOPE
1TJHH:1-113CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 11MER EPITOPE
1TJIH:1-113CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 17MER EPITOPE
1TZHB:1-113; H:1-113CRYSTAL STRUCTURE OF THE FAB YADS1 COMPLEXED WITH H-VEGF
1TZIB:1-113CRYSTAL STRUCTURE OF THE FAB YADS2 COMPLEXED WITH H-VEGF
1U8HB:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWAS
1U8IB:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAN
1U8JB:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAG
1U8KB:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASL
1U8LB:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE DLDRWAS
1U8MB:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKYAS
1U8NB:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKFAS
1U8OB:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKHAS
1U8PB:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ECDKWCS
1U8QB:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELEKWAS
1U91B:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG ENDKW-[DAP]-S (CYCLIC)
1U92B:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG E-[DAP]-DKWQS (CYCLIC)
1U93B:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG EQDKW-[DAP]-S (CYCLIC)
1U95B:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDHWAS
1UJ3B:301-417CRYSTAL STRUCTURE OF A HUMANIZED FAB FRAGMENT OF ANTI-TISSUE-FACTOR ANTIBODY IN COMPLEX WITH TISSUE FACTOR
1VHPA:VH-P8, NMR
2AGJH:1-120CRYSTAL STRUCTURE OF A GLYCOSYLATED FAB FROM AN IGM CRYOGLOBULIN WITH PROPERTIES OF A NATURAL PROTEOLYTIC ANTIBODY
2B0SH:1-113CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH MN PEPTIDE
2B1AH:1-113CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG1033 PEPTIDE
2B1HH:1-113CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE
2F5AH:1-132CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5
2F5BH:1-132CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH ITS GP41 EPITOPE
2FGWH:1-124X-RAY STRUCTURES OF FRAGMENTS FROM BINDING AND NONBINDING VERSIONS OF A HUMANIZED ANTI-CD18 ANTIBODY: STRUCTURAL INDICATIONS OF THE KEY ROLE OF VH RESIDUES 59 TO 65
2FJFB:1-120; D:1-120; F:1-120; H:1-120; I:1-120; K:1-120; N:1-120; P:1-120; R:1-120; T:1-120; V:1-120; X:1-120STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB
2FJGB:1-120; H:1-120STRUCTURE OF THE G6 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF
2H9GB:1-113; H:1-113CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5)
2NYYD:2-118CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
2NZ9D:2-118; F:2-118CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
2P8LB:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN
2P8MB:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN IN NEW CRYSTAL FORM
2P8PB:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASLW[N-AC]
2PR4H:1-132CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5
2PW1B:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWNSL
2PW2B:1-113CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWKSL
3LEVH:1-113HIV-1 ANTIBODY 2F5 IN COMPLEX WITH EPITOPE SCAFFOLD ES2
(-)
Human (Homo sapiens), cluster 1 [TaxId: 9606] (37)
1G9MH:1-129HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1G9NH:1-129HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1GC1H:1-129HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY
1HZHH:1-113; K:1-113CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN
1IQDB:1-114HUMAN FACTOR VIII C2 DOMAIN COMPLEXED TO HUMAN MONOCLONAL BO2C11 FAB.
1N0XH:1-113; K:1-113CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE
1RHHB:3-113; D:4-113CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION
1RZ7H:1-113CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 48D
1RZ8B:1-113; D:1-113CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B
1RZFH:2-113CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY E51
1RZGA:1-113; C:2-113CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
1RZIB:1-113; D:1-113; F:1-113; H:1-113; J:1-113; L:1-113; N:1-113; P:1-113CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
1RZJH:1-113HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1RZKH:1-113HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1TZGH:1-113; I:1-113CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41
1VGEH:1-122TR1.9 FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY
1YYLH:1-113; R:1001-1113CRYSTAL STRUCTURE OF CD4M33, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
1YYMH:1-113; R:1001-1113CRYSTAL STRUCTURE OF F23, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2DD8H:2-113CRYSTAL STRUCTURE OF SARS-COV SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH NEUTRALIZING ANTIBODY
2FX7H:1-113CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 16-RESIDUE PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
2FX8H:1-113; I:1-113; J:1-113; K:1-113CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
2FX9H:1-113; I:1-113CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
2G75A:2-113; C:2-113CRYSTAL STRUCTURE OF ANTI-SARS M396 ANTIBODY
2I5YH:1-113; R:1-113CRYSTAL STRUCTURE OF CD4M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2I60H:2-113; R:1-113CRYSTAL STRUCTURE OF [PHE23]M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2NXYD:3001-3128HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NXZD:3001-3128HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T257S, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY0D:3001-3128HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, T257S, V275C, S334A, S375W, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY1D:3001-3128HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C, T257S, S334A, S375W, Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY2D:3001-3128HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T123C, T257S, S334A, S375W, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY3D:3001-3128HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E267C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY4D:3001-3128HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E268C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY5H:3001-3128HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY6D:3001-3128HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY7H:1-113HIV-1 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH THE BROADLY NEUTRALIZING CD4-BINDING-SITE ANTIBODY B12
2QADD:1-113; H:1-113STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
4DVRH:1-119CRYSTAL STRUCTURE OF YU2 GP120 CORE IN COMPLEX WITH FAB 48D AND NBD-557
(-)
Human (Homo sapiens), cluster 2.1 [TaxId: 9606] (3)
1DN0B:1-120; D:1-120STRUCTURE OF THE FAB FRAGMENT FROM A HUMAN IGM COLD AGGLUTININ
1QLRB:1-120; D:1-120CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A HUMAN MONOCLONAL IGM COLD AGGLUTININ
7FABH:1-116CRYSTAL STRUCTURE OF HUMAN IMMUNOGLOBULIN FRAGMENT FAB NEW REFINED AT 2.0 ANGSTROMS RESOLUTION
(-)
Human (Homo sapiens), cluster 2.2 [TaxId: 9606] (2)
1MCOH:1-117THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION
2J6EH:1-113; I:1-113CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
(-)
Human (Homo sapiens), cluster 3 [TaxId: 9606] (33)
1ADQH:1-113CRYSTAL STRUCTURE OF A HUMAN IGM RHEUMATOID FACTOR FAB IN COMPLEX WITH ITS AUTOANTIGEN IGG FC
1AQKH:1-123THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR TETANUS TOXOID
1DEEB:501-621; D:1501-1621; F:2501-2621CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY
1DFBH:1-126STRUCTURE OF A HUMAN MONOCLONAL ANTIBODY FAB FRAGMENT AGAINST GP41 OF HUMAN IMMUNODEFICIENCY VIRUS TYPE I
1DQLH:CRYSTAL STRUCTURE OF AN UNLIGANDED (NATIVE) FV FROM A HUMAN IGM ANTI-PEPTIDE ANTIBODY
1HEZB:1-121; D:1-121ANTIBODY-ANTIGEN COMPLEX
1IGMH:THREE DIMENSIONAL STRUCTURE OF AN FV FROM A HUMAN IGM IMMUNOGLOBULIN
1NL0H:1-113CRYSTAL STRUCTURE OF HUMAN FACTOR IX GLA DOMAIN IN COMPLEX OF AN INHIBITORY ANTIBODY, 10C12
1U6AH:2-113CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV FAB F105
1W72H:1-113; I:1-113CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3
1Y0LB:1-113; D:1-113; F:1-113; H:1-113CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN
1Y18B:1-113; D:1-113; F:1-113; H:1-113FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN
1ZLSH:1-112FAB 2G12 + MAN4
1ZLUH:1-112; M:1-112FAB 2G12 + MAN5
1ZLVH:1-112; M:1-112FAB 2G12 + MAN7
1ZLWH:1-112; M:1-112FAB 2G12 + MAN8
2FB4H:1-119DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L-KETTE, LAMBDA-TYP, SUBGRUPPE I (GERMAN)
2GHWB:1-117; D:1-117CRYSTAL STRUCTURE OF SARS SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY, 80R
2IG2H:1-119DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L-KETTE, LAMBDA-TYP, SUBGRUPPE I (GERMAN)
2JB5H:3-120FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-1
2JB6B:3-120; H:3-120FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-2
2OQJB:1-112; E:1-112; H:1-112; K:1-112CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
2QQNH:1-113NEUROPILIN-1 B1 DOMAIN IN COMPLEX WITH A VEGF-BLOCKING FAB
3B2UC:1-121; F:1-121; H:1-121; J:1-121; N:1-121; Q:1-121; T:1-121; W:1-121CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3B2VH:1-121CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3BKYH:1-122CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY C2H7 FAB IN COMPLEX WITH A CD20 PEPTIDE
3C08H:2-121CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB/EMD72000 (FAB72000)
3C09C:2-121; H:2-121CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR
3CFJB:1-113; D:1-113; F:1-113; H:1-113CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM
3CFKB:1-113; D:1-113; F:1-113; H:1-113; I:1-113; K:1-113; N:1-113; P:1-113CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM
3DVGB:2-120CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU.3A8 BOUND TO K63-LINKED DI-UBIQUITIN
3DVNB:2-120; H:2-120CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU2.16 BOUND TO K63-LINKED DI-UBIQUITIN
8FABB:1-121; D:1-121CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE HUMAN MYELOMA IMMUNOGLOBULIN IGG HIL AT 1.8 ANGSTROMS RESOLUTION
(-)
Human (Homo sapiens), cluster 4 [TaxId: 9606] (4)
1Q1JH:1-113; I:1-113CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE
2B4CH:4-113CRYSTAL STRUCTURE OF HIV-1 JR-FL GP120 CORE PROTEIN CONTAINING THE THIRD VARIABLE REGION (V3) COMPLEXED WITH CD4 AND THE X5 ANTIBODY
3C2AH:1-113; I:1-113ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE
4M1DH:1-113; I:1-113CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN
(-)
Mouse (Mus musculus), cluster 1 [TaxId: 10090] (57)
1AIFB:1-121; H:1-121ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) FAB FROM MOUSE
1AXTH:1-113IMMUNE VERSUS NATURAL SELECTION: ANTIBODY ALDOLASES WITH THE RATES OF NATURAL ENZYMES
1CBVH:1-122AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE-FAB COMPLEX
1CK0H:1-106ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, UNLIGANDED FORM
1CLOH:1-113ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7
1DLFH:HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 5.25
1FL5B:1-113; H:1-113THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4.
1FL6B:1-113; H:1-113THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
1FLRH:1-1184-4-20 FAB FRAGMENT
1IAII:1-121IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
1KELH:1-115CATALYTIC ANTIBODY 28B4 FAB FRAGMENT COMPLEXED WITH HAPTEN (1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO] METHYLPHOSPHONIC ACID)
1KEMH:1-115CATALYTIC ANTIBODY 28B4 FAB FRAGMENT
1M71B:1-113CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE
1M7DB:1-113CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE
1M7IB:1-113CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A PENTASACCHARIDE
1MAMH:1-119CRYSTAL STRUCTURE TO 2.45 A RESOLUTION OF A MONOCLONAL FAB SPECIFIC FOR THE BRUCELLA A CELL WALL POLYSACCHARIDE ANTIGEN
1MCPH:1-121PHOSPHOCHOLINE BINDING IMMUNOGLOBULIN FAB MC/PC603. AN X-RAY DIFFRACTION STUDY AT 2.7 ANGSTROMS
1NBVH:1-122AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE-FAB COMPLEX
1PZ5B:1-113STRUCTURAL BASIS OF PEPTIDE-CARBOHYDRATE MIMICRY IN AN ANTIBODY COMBINING SITE
1Q72H:1-113ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE
1Q9KB:1-111S25-2 FAB UNLIGANDED 1
1Q9LB:1-111; D:1-111S25-2 FAB UNLIGANDED 2
1Q9OB:1-111; D:1-111S45-18 FAB UNLIGANDED
1Q9WB:1-111; D:1-111S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
1QYGH:1-113ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE
1RFDH:1-113ANTI-COCAINE ANTIBODY M82G2
1RIUH:1-113ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE
1RIVH:1-113ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META-OXYBENZOYLECGONINE
1SBSH:1-123CRYSTAL STRUCTURE OF AN ANTI-HCG FAB
1SM3H:1-113CRYSTAL STRUCTURE OF THE TUMOR SPECIFIC ANTIBODY SM3 COMPLEX WITH ITS PEPTIDE EPITOPE
1T66D:1-118; H:1-118THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
1V7MH:1-116; I:1-116HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
1V7NH:1-116; I:1-116; J:1-116; K:1-116HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
1WC7B:1-113; H:1-113FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE
1WCBB:1-113; H:1-113PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
2BMKB:1-113; H:1-113FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
2CK0H:1-106ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, COMPLEX WITH A SYNTHETIC CYCLIC PEPTIDE
2DLFH:HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 6.75
2MCPH:1-121REFINED CRYSTAL STRUCTURE OF THE MC/PC603 FAB-PHOSPHOCHOLINE COMPLEX AT 3.1 ANGSTROMS RESOLUTION
2R1WB:1-111CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R1XB:1-111CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R1YB:1-111CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R23B:1-111CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R2BB:1-111CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R2EB:1-111CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R2HB:1-111STRUCTURE OF S25-2 IN COMPLEX WITH KO
2UUDH:1-113; J:1-113CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5-OXAZOLONE NQ10-1.12 SCFV IN COMPLEX WITH THE HAPTEN
2ZKHH:1-116HUMAN THROMBOPOIETIN NEUTRALIZING ANTIBODY TN1 FAB
3BPCB:1-111CO-CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH 5-DEOXY-4-EPI-2,3-DEHYDRO KDO (4.8) KDO
3CK0H:1-106ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, COMPLEX WITH HUMAN ANGIOTENSIN II
3FO9B:1-113; H:1-113CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB' IN COMPLEX WITH HAPTEN 1,3-DIKETONE
3SY0B:1-111S25-2- A(2-8)-A(2-4)KDO TRISACCHARIDE COMPLEX
3T4YB:1-111S25-2- KDO MONOSACCHARIDE COMPLEX
3T65B:1-111S25-2- A(2-8)KDO DISACCHARIDE COMPLEX
3T77B:1-111S25-2- A(2-4)KDO DISACCHARIDE COMPLEX
4FABH:1-118THREE-DIMENSIONAL STRUCTURE OF A FLUORESCEIN-FAB COMPLEX CRYSTALLIZED IN 2-METHYL-2,4-PENTANEDIOL
4HGWB:1-112CRYSTAL STRUCTURE OF S25-2 IN COMPLEX WITH A 5,6-DEHYDRO-KDO DISACCHARIDE
(-)
Mouse (Mus musculus), cluster 2.1 [TaxId: 10090] (14)
1FL3A:2-116; H:2-116CRYSTAL STRUCTURE OF THE BLUE FLUORESCENT ANTIBODY (19G2) IN COMPLEX WITH STILBENE HAPTEN AT 277K
1I9IH:1-118NATIVE CRYSTAL STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
1I9JH:1-118TESTOSTERONE COMPLEX STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
1JGUH:1-113STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4
1JGVH:1-113STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4
1KFAH:2-121; I:3-121CRYSTAL STRUCTURE OF FAB FRAGMENT COMPLEXED WITH GIBBERELLIN A4
1L7TH:1-118CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB FRAGMENT
1LO0H:1-119; Y:1-119CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX
1LO2H:1-119; Y:1-119RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY
1LO3H:1-119; Y:1-119RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY: PRODUCT ANALOGUE
1LO4H:1-118RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 9D9
1UB5A:1-116; H:1-116CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH HAPTEN AT 100K
1UB6A:2-116; H:2-116CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH SERA LIGAND
1VPOH:1-118CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB IN COMPLEX WITH TESTOSTERONE
(-)
Mouse (Mus musculus), cluster 2.2 [TaxId: 10090] (58)
1AR1C:STRUCTURE AT 2.7 ANGSTROM RESOLUTION OF THE PARACOCCUS DENITRIFICANS TWO-SUBUNIT CYTOCHROME C OXIDASE COMPLEXED WITH AN ANTIBODY FV FRAGMENT
1BFVH:MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
1BLNB:1-113; D:1-113ANTI-P-GLYCOPROTEIN FAB MRK-16
1BM3H:1-125IMMUNOGLOBULIN OPG2 FAB-PEPTIDE COMPLEX
1BZ7B:1-122FAB FRAGMENT FROM MURINE ASCITES
1CFVH:MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
1CLYH:1-113IGG FAB (HUMAN IGG1, KAPPA) CHIMERIC FRAGMENT (CBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
1CLZH:1-113IGG FAB (IGG3, KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
1DSFH:THE CRYSTAL STRUCTURE OF THE DISULFIDE-STABILIZED FV FRAGMENT OF ANTICANCER ANTIBODY B1: CONFORMATIONAL INFLUENCE OF AN ENGINEERED DISULFIDE BOND
1EJOH:2501-2619FAB FRAGMENT OF NEUTRALISING MONOCLONAL ANTIBODY 4C4 COMPLEXED WITH G-H LOOP FROM FMDV.
1F4WH:1-117CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN
1F4XH:1-117CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN
1F4YH:1-117CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN
1FH5H:4-120CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MONOCLONAL ANTIBODY MAK33
1FRGH:218-336CRYSTAL STRUCTURE, SEQUENCE, AND EPITOPE MAPPING OF A PEPTIDE COMPLEX OF AN ANTI-INFLUENZA HA PEPTIDE ANTIBODY FAB 26(SLASH)9: FINE-TUNING ANTIBODY SPECIFICITY
1H0DB:1-113CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN IN COMPLEX WITH FAB FRAGMENT OF ITS MONOCLONAL ANTIBODY MAB 26-2F
1H3PH:1-113STRUCTURAL CHARACTERISATION OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE PRES1 REGION OF THE HEPATITIS B VIRUS
1HILB:1-112; D:1-112STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIGEN-ANTIBODY RECOGNITION
1HIML:1-112; M:1-112STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIBODY-ANTIGEN RECOGNITION
1HINH:1-112STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIBODY-ANTIGEN RECOGNITION
1I8IB:CRYSTAL STRUCTURE OF DSFV MR1 IN COMPLEX WITH THE PEPTIDE ANTIGEN OF THE MUTANT EPIDERMAL GROWTH FACTOR RECEPTOR, EGFRVIII, AT ROOM TEMPERATURE
1I8KB:CRYSTAL STRUCTURE OF DSFV MR1 IN COMPLEX WITH THE PEPTIDE ANTIGEN OF THE MUTANT EPIDERMAL GROWTH FACTOR RECEPTOR, EGFRVIII, AT LIQUID NITROGEN TEMPERATURE
1IFHH:1-112A DETAILED ANALYSIS OF THE FREE AND BOUND CONFORMATION OF AN ANTIBODY: X-RAY STRUCTURES OF ANTI-PEPTIDE FAB 17(SLASH)9 AND THREE DIFFERENT FAB-PEPTIDE COMPLEXES
1IGCH:1-119IGG1 FAB FRAGMENT (MOPC21) COMPLEX WITH DOMAIN III OF PROTEIN G FROM STREPTOCOCCUS
1IGFH:1-113; J:1-113CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
1IGTB:1-114; D:1-114STRUCTURE OF IMMUNOGLOBULIN
1IKFH:1-126A CONFORMATION OF CYCLOSPORIN A IN AQUEOUS ENVIRONMENT REVEALED BY THE X-RAY STRUCTURE OF A CYCLOSPORIN-FAB COMPLEX
1INDH:1-114HOW THE ANTI-(METAL CHELATE) ANTIBODY CHA255 IS SPECIFIC FOR THE METAL ION OF ITS ANTIGEN: X-RAY STRUCTURES FOR TWO FAB'(SLASH)HAPTEN COMPLEXES WITH DIFFERENT METALS IN THE CHELATE
1INEH:1-114HOW THE ANTI-(METAL CHELATE) ANTIBODY CHA255 IS SPECIFIC FOR THE METAL ION OF ITS ANTIGEN: X-RAY STRUCTURES FOR TWO FAB'(SLASH)HAPTEN COMPLEXES WITH DIFFERENT METALS IN THE CHELATE
1KNOB:1-119; D:1-119; F:1-119CRYSTAL STRUCTURE OF THE COMPLEX OF A CATALYTIC ANTIBODY FAB WITH A TRANSITION STATE ANALOG: STRUCTURAL SIMILARITIES IN ESTERASE-LIKE ABZYMES
1MF2H:1-113; N:1-113ANTI HIV1 PROTEASE FAB COMPLEX
1MQKH:CRYSTAL STRUCTURE OF THE UNLIGANDED FV-FRAGMENT OF THE ANTI-CYTOCHROME C OXIDASE ANTIBODY 7E2
1OPGH:1-125OPG2 FAB FRAGMENT
1OTSC:2-121; E:2-121STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL AND FAB COMPLEX
1OTTC:2-121; E:2-121STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148A MUTANT AND FAB COMPLEX
1OTUC:2-121; E:2-121STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148Q MUTANT AND FAB COMPLEX
1QFWI:TERNARY COMPLEX OF HUMAN CHORIONIC GONADOTROPIN WITH FV ANTI ALPHA SUBUNIT AND FV ANTI BETA SUBUNIT
1QKZH:1-113FAB FRAGMENT (MN14C11.6) IN COMPLEX WITH A PEPTIDE ANTIGEN DERIVED FROM NEISSERIA MENINGITIDIS P1.7 SEROSUBTYPE ANTIGEN AND DOMAIN II FROM STREPTOCOCCAL PROTEIN G
1QLEH:CRYO-STRUCTURE OF THE PARACOCCUS DENITRIFICANS FOUR-SUBUNIT CYTOCHROME C OXIDASE IN THE COMPLETELY OXIDIZED STATE COMPLEXED WITH AN ANTIBODY FV FRAGMENT
1R24B:1-122; D:1-122FAB FROM MURINE IGG3 KAPPA
1UCBH:1-113STRUCTURE OF UNCOMPLEXED FAB COMPARED TO COMPLEX (1CLY, 1CLZ)
1UZ6F:1-113; H:1-113; P:1-113; W:1-113ANTI-LEWIS X FAB FRAGMENT UNCOMPLEXED
1UZ8B:1-113; H:1-113ANTI-LEWIS X FAB FRAGMENT IN COMPLEX WITH LEWIS X
2BFVH:MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
2FBJH:1-118REFINED CRYSTAL STRUCTURE OF THE GALACTAN-BINDING IMMUNOGLOBULIN FAB J539 AT 1.95-ANGSTROMS RESOLUTION
2GFBB:1-119; D:1-119; F:1-119; H:1-119; J:1-119; L:1-119; N:1-119; P:1-119CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
2H1PH:301-420THE THREE-DIMENSIONAL STRUCTURES OF A POLYSACCHARIDE BINDING ANTIBODY TO CRYPTOCOCCUS NEOFORMANS AND ITS COMPLEX WITH A PEPTIDE FROM A PHAGE DISPLAY LIBRARY: IMPLICATIONS FOR THE IDENTIFICATION OF PEPTIDE MIMOTOPES
2HFFB:1-113; H:1-113CRYSTAL STRUCTURE OF CB2 FAB
2HFGH:1-113CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB
2HRPH:1-113; N:1-113ANTIGEN-ANTIBODY COMPLEX
2IGFH:1-113CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
2J4WH:1-112STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
2J5LC:1-112STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
4ENEC:1-121; E:2-121STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX
4KJQC:2-121; E:2-121STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
4KK8C:2-121; E:2-121STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
4KKLC:2-121; E:2-121STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTA NC CONSTRUCT IN 100MM FLUORIDE
4LOUC:1-121; E:2-121STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE
(-)
Mouse (Mus musculus), cluster 3.1 [TaxId: 10090] (31)
12E8H:1-114; P:1-1142E8 FAB FRAGMENT
15C8H:1-113CATALYTIC ANTIBODY 5C8, FREE FAB
1A3RH:2-119FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID PROTEIN VP2 (RESIDUES 156-170)
1A5FH:1-120FAB FRAGMENT OF A MONOCLONAL ANTI-E-SELECTIN ANTIBODY
1AHWB:1-117; E:1-117A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
1AJ7H:1-114IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
1AP2B:; D:SINGLE CHAIN FV OF C219
1BBDH:1-119THREE DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY TO HUMAN RHINOVIRUS SEROTYPE 2
1CR9H:1-110CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4
1CU4H:3-110CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4 IN COMPLEX WITH ITS PEPTIDE EPITOPE
1DVFD:IDIOTOPIC ANTIBODY D1.3 FV FRAGMENT-ANTIIDIOTOPIC ANTIBODY E5.2 FV FRAGMENT COMPLEX
1DZBA:1-117; B:1-117CRYSTAL STRUCTURE OF PHAGE LIBRARY-DERIVED SINGLE-CHAIN FV FRAGMENT 1F9 IN COMPLEX WITH TURKEY EGG-WHITE LYSOZYME
1FGNH:1-117MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR
1GAFH:1-11448G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
1HKLH:1-114FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY
1IL1A:3-121CRYSTAL STRUCTURE OF G3-519, AN ANTI-HIV MONOCLONAL ANTIBODY
1JNLH:1-114CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1JNNH:1-114CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1K6QH:1-117CRYSTAL STRUCTURE OF ANTIBODY FAB FRAGMENT D3
1MOEA:120-240; B:120-240THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE.
1QBLH:1-112FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION
1QBMH:1-112FAB E8B ANTIBODY, X-RAY STRUCTURE AT 2.37 ANGSTROMS RESOLUTION
1QOKA:27-147MFE-23 AN ANTI-CARCINOEMBRYONIC ANTIGEN SINGLE-CHAIN FV ANTIBODY
1WEJH:1-112IGG1 FAB FRAGMENT (OF E8 ANTIBODY) COMPLEXED WITH HORSE CYTOCHROME C AT 1.8 A RESOLUTION
25C8H:1-113CATALYTIC ANTIBODY 5C8, FAB-HAPTEN COMPLEX
2AP2B:; D:SINGLE CHAIN FV OF C219 IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
2BDNH:1-117CRYSTAL STRUCTURE OF HUMAN MCP-1 BOUND TO A BLOCKING ANTIBODY, 11K2
2GSIB:2-114; D:2-114; F:2-114; H:2-114CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
2HH0H:1-149STRUCTURE OF AN ANTI-PRP FAB, P-CLONE, IN COMPLEX WITH ITS COGNATE BOVINE PEPTIDE EPITOPE.
2RCSH:1-114IMMUNOGLOBULIN 48G7 GERMLINE FAB-AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
35C8H:1-113CATALYTIC ANTIBODY 5C8, FAB-INHIBITOR COMPLEX
(-)
Mouse (Mus musculus), cluster 3.2 [TaxId: 10090] (177)
1A0QH:2-11429G11 COMPLEXED WITH PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL] PHOSPHONATE
1A14H:COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 5 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
1A3LH:1-113CATALYSIS OF A DISFAVORED REACTION: AN ANTIBODY EXO DIELS-ALDERASE-TSA-INHIBITOR COMPLEX AT 1.95 A RESOLUTION
1A6TB:1-113; D:1-113FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE
1A6UH:B1-8 FV FRAGMENT
1A6VH:; I:; J:B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-3-NITROPHENYL) ACETATE COMPOUND
1A6WH:B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-5-IODO-3-NITROPHENYL) ACETATE COMPOUND
1AE6H:1-114IGG-FAB FRAGMENT OF MOUSE MONOCLONAL ANTIBODY CTM01
1AFVH:1-120; K:1-120HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
1AXSB:1-113; H:1-113MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN
1B4JH:1-117COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY
1BBJB:1-115; H:1-115CRYSTAL STRUCTURE OF A CHIMERIC FAB' FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS
1BOGB:1-112ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-HOMOLOGOUS PEPTIDE
1BQLH:2-116STRUCTURE OF AN ANTI-HEL FAB FRAGMENT COMPLEXED WITH BOBWHITE QUAIL LYSOZYME
1C5BH:1-113DECARBOXYLASE CATALYTIC ANTIBODY 21D8 UNLIGANDED FORM
1C5CH:1-113DECARBOXYLASE CATALYTIC ANTIBODY 21D8-HAPTEN COMPLEX
1CFNB:1-112ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-RELATED PEPTIDE
1CFQB:1-112ANTI-P24 (HIV-1) FAB FRAGMENT CB41
1CFSB:1-112ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-UNRELATED PEPTIDE
1CFTB:1-112ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-UNRELATED D-PEPTIDE
1CGSH:1-117LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
1CICB:1-117IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
1D5BB:1-113; H:1-113UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY
1D5IH:1-113UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY
1D6VH:1-113CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION
1E4WH:1-110CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
1E4XH:1-110; I:1-110CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
1E6JH:1-120CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN (P24) IN COMPLEX WITH FAB13B5
1E6OH:1-120CRYSTAL STRUCTURE OF FAB13B5 AGAINST HIV-1 CAPSID PROTEIN P24
1EAPB:1-124CRYSTAL STRUCTURE OF A CATALYTIC ANTIBODY WITH A SERINE PROTEASE ACTIVE SITE
1EGJH:1-113DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY
1EHLH:1-11364M-2 ANTIBODY FAB COMPLEXED WITH D(5HT)(6-4)T
1EMTH:1-116FAB ANTIBODY FRAGMENT OF AN C60 ANTIFULLERENE ANTIBODY
1EO8H:1-113INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
1F11B:1-113; D:1-113F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY
1F3DH:1-121; K:1-121CATALYTIC ANTIBODY 4B2 IN COMPLEX WITH ITS AMIDINIUM HAPTEN.
1FAIH:1-123THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9, FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
1FBIH:1-121; Q:1-121CRYSTAL STRUCTURE OF A CROSS-REACTION COMPLEX BETWEEN FAB F9.13.7 AND GUINEA-FOWL LYSOZYME
1FIGH:1-113ROUTES TO CATALYSIS: STRUCTURE OF A CATALYTIC ANTIBODY AND COMPARISON WITH ITS NATURAL COUNTERPART
1FORH:1-120STRUCTURE DETERMINATION OF AN FAB FRAGMENT THAT NEUTRALIZES HUMAN RHINOVIRUS AND ANALYSIS OF THE FAB-VIRUS COMPLEX
1FPTH:1-113THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN THE FAB FRAGMENT OF AN NEUTRALIZING ANTIBODY FOR TYPE 1 POLIOVIRUS AND ITS VIRAL EPITOPE
1FSKC:1-118; F:1-118; I:1-118; L:1-118COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
1H8NA:132-243THREE-DIMENSIONAL STRUCTURE OF ANTI-AMPICILLIN SINGLE CHAIN FV FRAGMENT FROM PHAGE-DISPLAYED MURINE ANTIBODY LIBRARIES
1H8OA:132-243; B:133-243THREE-DIMENSIONAL STRUCTURE OF ANTI-AMPICILLIN SINGLE CHAIN FV FRAGMENT.
1H8SA:132-243; B:133-243THREE-DIMENSIONAL STRUCTURE OF ANTI-AMPICILLIN SINGLE CHAIN FV FRAGMENT COMPLEXED WITH THE HAPTEN.
1HH6B:1-112ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE
1HH9B:1-112ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE
1HI6B:1-112ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE
1I3GH:CRYSTAL STRUCTURE OF AN AMPICILLIN SINGLE CHAIN FV, FORM 1, FREE
1I8MB:1-113; H:1-113CRYSTAL STRUCTURE OF A RECOMBINANT ANTI-SINGLE-STRANDED DNA ANTIBODY FRAGMENT COMPLEXED WITH DT5
1IGIH:2-11426-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
1IGJB:2-114; D:2-11426-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
1IGYB:2-113; D:2-113STRUCTURE OF IMMUNOGLOBULIN
1IQWH:1-121CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI-HUMAN FAS ANTIBODY HFE7A
1J05B:; H:THE CRYSTAL STRUCTURE OF ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY T84.66 FV FRAGMENT
1JFQH:302-421ANTIGEN-BINDING FRAGMENT OF THE MURINE ANTI-PHENYLARSONATE ANTIBODY 36-71, "FAB 36-71"
1JHLH:THREE-DIMENSIONAL STRUCTURE OF A HETEROCLITIC ANTIGEN-ANTIBODY CROSS-REACTION COMPLEX
1JN6B:1-117CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1JNHB:1-117; D:1-117; F:1-117; H:1-117CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1K4CA:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF K+
1K4DA:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+
1KB5H:1-113MURINE T-CELL RECEPTOR VARIABLE DOMAIN/FAB COMPLEX
1KEGH:1-113ANTIBODY 64M-2 FAB COMPLEXED WITH DTT(6-4)TT
1KN2H:1-113CATALYTIC ANTIBODY D2.3 COMPLEX
1KN4H:1-113CATALYTIC ANTIBODY D2.3 COMPLEX
1KTRH:CRYSTAL STRUCTURE OF THE ANTI-HIS TAG ANTIBODY 3D5 SINGLE-CHAIN FRAGMENT (SCFV) IN COMPLEX WITH A OLIGOHISTIDINE PEPTIDE
1LMKA:2-127; C:2-127; E:2-127; G:2-127THE STRUCTURE OF A BIVALENT DIABODY
1MEXH:1-113ANTIBODY CATALYSIS OF A BIMOLECULAR CYCLOADDITION REACTION
1MFAH:251-367STRUCTURE OF A SINGLE-CHAIN FV FRAGMENT COMPLEXED WITH A CARBOHYDRATE ANTIGEN AT 1.7 ANGSTROMS RESOLUTION
1MFBH:251-367HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
1MFCH:251-367HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
1MFDH:251-367THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE
1MFEH:251-367RECOGNITION OF A CELL-SURFACE OLIGO-SACCHARIDE OF PATHOGENIC SALMONELLA BY AN ANTIBODY FAB FRAGMENT
1MH5B:2-113; H:2-113THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
1MIEH:5-113CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393
1MIMH:1-115IGG FAB FRAGMENT (CD25-BINDING)
1MJ7H:4-113CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393 AND A TRANSITION-STATE ANALOG
1MJ8H:2-113HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-126
1MJJB:1-113; H:1-113HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION-STATE ANALOG
1MJUH:1-1131.22 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12
1MLBB:1-118MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME
1MLCB:1-118; D:1-118MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME COMPLEXED WITH LYSOZYME
1MNUH:1-121UNLIGANDED BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
1MPAH:1-121BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
1MRCH:1-115PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
1MRDH:2-115PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
1MREH:1-115PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
1MRFH:2-115PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
1MVUB:SINGLE CHAIN FV OF C219 HEAVY CHAIN V101L MUTANT IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
1N7ML:1-114GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN
1NGPH:1-120N1G9 (IGG1-LAMBDA) FAB FRAGMENT COMPLEXED WITH (4-HYDROXY-3-NITROPHENYL) ACETATE
1NGQH:1-120N1G9 (IGG1-LAMBDA) FAB FRAGMENT
1NGWB:1-114; H:1-114CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
1NGXB:1-114; H:1-114CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
1NGYB:1-114CHIMERIC MATURE FAB 7G12-APO
1NGZB:1-114CHIMERIC GERMLINE FAB 7G12-APO
1NJ9B:1-113; H:1-113COCAINE HYDROLYTIC ANTIBODY 15A10
1NMAH:N9 NEURAMINIDASE COMPLEXES WITH ANTIBODIES NC41 AND NC10: EMPIRICAL FREE-ENERGY CALCULATIONS CAPTURE SPECIFICITY TRENDS OBSERVED WITH MUTANT BINDING DATA
1NMBH:THE STRUCTURE OF A COMPLEX BETWEEN THE NC10 ANTIBODY AND INFLUENZA VIRUS NEURAMINIDASE AND COMPARISON WITH THE OVERLAPPING BINDING SITE OF THE NC41 ANTIBODY
1NMCB:; H:COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
1NQBA:2-120; C:2-120TRIVALENT ANTIBODY FRAGMENT
1P2CB:301-413; E:1201-1313CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
1P7KB:1-113; H:1-113CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES)
1PG7X:1-113; Z:1-113MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
1PKQB:1-113; G:1-113MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX
1PLGH:1-117EVIDENCE FOR THE EXTENDED HELICAL NATURE OF POLYSACCHARIDE EPITOPES. THE 2.8 ANGSTROMS RESOLUTION STRUCTURE AND THERMODYNAMICS OF LIGAND BINDING OF AN ANTIGEN BINDING FRAGMENT SPECIFIC FOR ALPHA-(2->8)-POLYSIALIC ACID
1PSKH:1-114THE CRYSTAL STRUCTURE OF AN FAB FRAGMENT THAT BINDS TO THE MELANOMA-ASSOCIATED GD2 GANGLIOSIDE
1Q0XH:1-113ANTI-MORPHINE ANTIBODY 9B1 UNLIGANDED FORM
1Q0YH:1-113ANTI-MORPHINE ANTIBODY 9B1 COMPLEXED WITH MORPHINE
1QFUH:1-113INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
1QFWH:TERNARY COMPLEX OF HUMAN CHORIONIC GONADOTROPIN WITH FV ANTI ALPHA SUBUNIT AND FV ANTI BETA SUBUNIT
1QNZH:NMR STRUCTURE OF THE 0.5B ANTI-HIV ANTIBODY COMPLEX WITH THE GP120 V3 PEPTIDE
1R3IH:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+
1R3JB:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF TL+
1R3KB:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+
1R3LB:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+
1RIHH:1-113CRYSTAL STRUCTURE OF FAB 14F7, A UNIQUE ANTI-TUMOR ANTIBODY SPECIFIC FOR N-GLYCOLYL GM3
1RMFH:1-119STRUCTURES OF A MONOCLONAL ANTI-ICAM-1 ANTIBODY R6.5 FRAGMENT AT 2.8 ANGSTROMS RESOLUTION
1RUQH:1-113CRYSTAL STRUCTURE (H) OF U.V.-IRRADIATED DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED IN HOUSE.
1RURH:1-113CRYSTAL STRUCTURE (I) OF NATIVE DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1.
1RVFH:FAB COMPLEXED WITH INTACT HUMAN RHINOVIRUS
1S5HB:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+
1SY6H:1-119CRYSTAL STRUCTURE OF CD3GAMMAEPSILON HETERODIMER IN COMPLEX WITH OKT3 FAB FRAGMENT
1UM4H:3-119CATALYTIC ANTIBODY 21H3 WITH HAPTEN
1UM5H:3-119CATALYTIC ANTIBODY 21H3 WITH ALCOHOL SUBSTRATE
1UM6H:3-119CATALYTIC ANTIBODY 21H3
1UWEH:4-113; V:4-113; Y:4-113MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1UWGH:3-113; Y:3-113MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1XIWD:; H:CRYSTAL STRUCTURE OF HUMAN CD3-E/D DIMER IN COMPLEX WITH A UCHT1 SINGLE-CHAIN ANTIBODY FRAGMENT
1YECH:1-113STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.3)
1YEDB:1-113; H:1-113STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
1YEEH:1-113STRUCTURE OF A CATALYTIC ANTIBODY, IGG2A FAB FRAGMENT (D2.5)
1YEFH:1-113STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH SUBSTRATE ANALOGUE
1YEGH:1-113STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH REACTION PRODUCT
1YEHH:1-113STRUCTURE OF IGG2A FAB FRAGMENT
1YEIH:1-113CATALYTIC ANTIBODY D2.3 COMPLEX
1YEJH:1-113CATALYTIC ANTIBODY COMPLEX
1YEKH:1-113CATALYTIC ANTIBODY D2.3 COMPLEX
1YUHB:1-118; H:1-118FAB FRAGMENT
1ZA6B:2-115; D:2-115; F:2-115; H:2-115THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
1ZWIA:1-118STRUCTURE OF MUTANT KCSA POTASSIUM CHANNEL
2ATKA:1-118STRUCTURE OF A MUTANT KCSA K+ CHANNEL
2BOBA:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA)
2CGRH:1-117LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
2DTG  [entry was replaced by entry 4ZXB without any SCOP domain information]
2DWDA:1-118CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN TL+
2DWEA:1-118CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN RB+
2F19H:1-123THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9, FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
2FATH:1-113AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE
2FD6H:1-113STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR IN COMPLEX WITH UROKINASE RECEPTOR AND AN ANTI-UPAR ANTIBODY AT 1.9 A
2HJFA:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA)
2HVJA:2-118CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN LOW K+
2HVKA:1-118CRYSTAL STRUCTURE OF THE KCSA-FAB-TBA COMPLEX IN HIGH K+
2IFFH:2-116STRUCTURE OF AN ANTIBODY-LYSOZYME COMPLEX: EFFECT OF A CONSERVATIVE MUTATION
2IH1A:1-118ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
2IH3A:1-118ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
2ITDA:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX IN BARIUM CHLORIDE
2JELH:1-113JEL42 FAB/HPR COMPLEX
2JK5A:1-118POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K
2MPAH:1-121BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
2NLJB:1-118POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL
2P7TA:1-118CRYSTAL STRUCTURE OF KCSA MUTANT
2PCPB:1-113; D:1-113ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
2W0FA:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM
3BT2H:1-113STRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX
3FB5A:1-118KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112
3FCTB:1-114; D:1-114MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
3GB7A:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+
3IGAA:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+
3OR6A:1-118ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71Q
3OR7A:1-118ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71I
3STLA:1-118KCSA POTASSIUM CHANNEL MUTANT Y82C WITH CADMIUM BOUND
3STZA:1-118KCSA POTASSIUM CHANNEL MUTANT Y82C WITH NITROXIDE SPIN LABEL
4LBEA:1-118STRUCTURE OF KCSA WITH R122A MUTATION
4LCUA:1-118STRUCTURE OF KCSA WITH E118A MUTATION
4MSWA:1-118Y78 ESTER MUTANT OF KCSA IN HIGH K+
6FABH:1-121THREE-DIMENSIONAL STRUCTURE OF MURINE ANTI-P-AZOPHENYLARSONATE FAB 36-71. 1. X-RAY CRYSTALLOGRAPHY, SITE-DIRECTED MUTAGENESIS, AND MODELING OF THE COMPLEX WITH HAPTEN
(-)
Mouse (Mus musculus), cluster 3.3 [TaxId: 10090] (1)
1CT8B:1-113; D:1-113CATALYTIC ANTIBODY 7C8 COMPLEX
(-)
Mouse (Mus musculus), cluster 4 [TaxId: 10090] (34)
1A4JB:1-119; H:1-119DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
1A4KB:1-119; H:1-119DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
1BJ1H:1-123; K:1-123VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
1C1EH:1-119CRYSTAL STRUCTURE OF A DIELS-ALDERASE CATALYTIC ANTIBODY 1E9 IN COMPLEX WITH ITS HAPTEN
1CL7H:1-113ANTI HIV1 PROTEASE FAB
1CZ8H:1-123; Y:1-123VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
1DBAH:1-112THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB' AND PROGESTERONE-FAB' COMPLEX
1DBBH:1-112THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB' AND PROGESTERONE-FAB' COMPLEX
1DBJH:1-112MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1DBKH:1-112MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1DBMH:1-112MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1FJ1B:1-114; D:1-114LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
1GHFH:1-115ANTI-ANTI-IDIOTYPE GH1002 FAB FRAGMENT
1I7ZB:1-113; D:1-113ANTIBODY GNC92H2 BOUND TO LIGAND
1IAIH:1-121IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
1JGLH:1-113CRYSTAL STRUCTURE OF IMMUNOGLOBULIN FAB FRAGMENT COMPLEXED WITH 17-BETA-ESTRADIOL
1JHKH:2-113CRYSTAL STRUCTURE OF THE ANTI-ESTRADIOL ANTIBODY 57-2
1JP5A:128-247; B:128-247CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N-TERMINUS OF HIV-1 PROTEASE
1MHHB:1-113; D:1-113ANTIBODY-ANTIGEN COMPLEX
1N4XH:; I:STRUCTURE OF SCFV 1696 AT ACIDIC PH
1N64H:1-113CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6
1NCAH:1-113REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
1NCBH:1-113CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
1NCCH:1-113CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
1NCDH:1-113REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
1NLBH:1-113CRYSTAL STRUCTURE OF ANTI-HCV MONOCLONAL ANTIBODY 19D9D6
1OB1B:1-113; E:1-113CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
1SVZA:128-247; B:128-247CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N-TERMINUS OF HIV-2 PROTEASE
1TETH:1-112CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS
1TPXB:1-113; C:1-107OVINE RECOMBINANT PRP(114-234), ARQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY
1TQBB:1-113; C:1-107OVINE RECOMBINANT PRP(114-234), VRQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY
1TQCB:1-113; C:1-107OVINE RECOMBINANT PRP(114-234), ARR VARIANT IN COMPLEX WITH THE VRQ14 FAB FRAGMENT (IGG2A)
1YMHB:1-113; D:1-113ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
2DBLH:1-112MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
(-)
Mouse (Mus musculus), cluster 5 [TaxId: 10090] (36)
1A2YB:HEN EGG WHITE LYSOZYME, D18A MUTANT, IN COMPLEX WITH MOUSE MONOCLONAL ANTIBODY D1.3
1A7NH:FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) VARIANT FOR CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL
1A7OH:FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) R96L DELETION MUTANT ON VARIANT FOR CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL
1A7PH:FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) ENGINEERED MUTANT PRO95L->SER ON VARIANT CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL
1A7QH:FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) HIGH AFFINITY EXPRESSED VARIANT CONTAINING SER26L->GLY, ILE29L->THR, GLU81L->ASP, THR97L->SER, PRO240H->LEU, ASP258H->ALA, LYS281H->GLU, ASN283H->ASP AND LEU312H->VAL
1A7RH:FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) VARIANT CHAIN L GLU81->ASP
1CICD:1-116IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
1DL7H:THE STRUCTURAL BASIS OF REPERTOIRE SHIFT IN AN IMMUNE RESPONSE TO PHOSPHOCHOLINE
1DVFB:IDIOTOPIC ANTIBODY D1.3 FV FRAGMENT-ANTIIDIOTOPIC ANTIBODY E5.2 FV FRAGMENT COMPLEX
1FDLH:1-116CRYSTALLOGRAPHIC REFINEMENT OF THE THREE-DIMENSIONAL STRUCTURE OF THE FAB D1.3-LYSOZYME COMPLEX AT 2.5-ANGSTROMS RESOLUTION
1FE8H:1-115; I:1-115; J:1-115CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
1FNSH:215-336CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN I546V MUTANT IN COMPLEX WITH THE FUNCTION BLOCKING FAB NMC4
1G7HB:CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3(VLW92A)
1G7IB:CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92F)
1G7JB:CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92H)
1G7LB:CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92S)
1G7MB:CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92V)
1GIGH:1-120REFINED THREE-DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A MURINE IGG1, LAMBDA ANTIBODY
1IBGH:2-113STRUCTURE AND SPECIFICITY OF THE ANTI-DIGOXIN ANTIBODY 40-50
1KIPB:FV MUTANT Y(B 32)A (VH DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME
1KIQB:FV MUTANT Y(B 101)F (VH DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME
1KIRB:FV MUTANT Y(A 50)S (VL DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME
1NC2B:1-120; D:1-120CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y-DOTA
1NC4B:1-120; D:1-120CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD-DOTA
1NLDH:1-112FAB FRAGMENT OF A NEUTRALIZING ANTIBODY DIRECTED AGAINST AN EPITOPE OF GP41 FROM HIV-1
1OAKH:215-336CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB
1P4BH:THREE-DIMENSIONAL STRUCTURE OF A SINGLE CHAIN FV FRAGMENT COMPLEXED WITH THE PEPTIDE GCN4(7P-14P).
1P4IH:CRYSTAL STRUCTURE OF SCFV AGAINST PEPTIDE GCN4
1T4KB:1-113; D:1-113CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
1VFAB:BOUND WATER MOLECULES AND CONFORMATIONAL STABILIZATION HELP MEDIATE AN ANTIGEN-ANTIBODY ASSOCIATION
1VFBB:BOUND WATER MOLECULES AND CONFORMATIONAL STABILIZATION HELP MEDIATE AN ANTIGEN-ANTIBODY ASSOCIATION
2VIRB:1-120INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
2VISB:1-120INFLUENZA VIRUS HEMAGGLUTININ, (ESCAPE) MUTANT WITH THR 131 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY
2VITB:1-120INFLUENZA VIRUS HEMAGGLUTININ, MUTANT WITH THR 155 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY
43C9B:; D:; F:; H:CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY
43CAB:; D:; F:; H:CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY WITH BOUND P-NITROPHENOL
(-)
Mouse (Mus musculus), cluster 6 [TaxId: 10090] (12)
1ETZB:1-126; H:1-126THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB, NC10.14, SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS
1GGBH:1-112MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY
1GGCH:1-112MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY
1GGIH:1-112; J:1-112CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN
1HYSD:1-123CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RNA:DNA
1J5OH:1-123CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE-PRIMER
1JRHH:1-113COMPLEX (ANTIBODY/ANTIGEN)
1N5YH:1-123HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
1N6QH:1-123HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
1R0AH:1-123CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLY TETHERED TO DNA TEMPLATE-PRIMER SOLVED TO 2.8 ANGSTROMS
1T03H:1-123HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIR TERMINATED TEMPLATE-PRIMER (COMPLEX P)
2HMID:1-123HIV-1 REVERSE TRANSCRIPTASE/FRAGMENT OF FAB 28/DNA COMPLEX
(-)
Mouse (Mus musculus), cluster 7.1 [TaxId: 10090] (38)
1AY1H:1-115ANTI TAQ FAB TP7
1BAFH:1-1152.9 ANGSTROMS RESOLUTION STRUCTURE OF AN ANTI-DINITROPHENYL-SPIN-LABEL MONOCLONAL ANTIBODY FAB FRAGMENT WITH BOUND HAPTEN
1BGXH:5-115TAQ POLYMERASE IN COMPLEX WITH TP7, AN INHIBITORY FAB
1C12B:301-413INSIGHT IN ODORANT PERCEPTION: THE CRYSTAL STRUCTURE AND BINDING CHARACTERISTICS OF ANTIBODY FRAGMENTS DIRECTED AGAINST THE MUSK ODORANT TRASEOLIDE
1CF8H:1-113CONVERGENCE OF CATALYTIC ANTIBODY AND TERPENE CYCLASE MECHANISMS: POLYENE CYCLIZATION DIRECTED BY CARBOCATION-PI INTERACTIONS
1EZVX:STRUCTURE OF THE YEAST CYTOCHROME BC1 COMPLEX CO-CRYSTALLIZED WITH AN ANTIBODY FV-FRAGMENT
1F58H:1-113IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 24-RESIDUE PEPTIDE (RESIDUES 308-333 OF HIV-1 GP120 (MN ISOLATE) WITH ALA TO AIB SUBSTITUTION AT POSITION 323
1F8TH:1-113FAB (LNKB-2) OF MONOCLONAL ANTIBODY, CRYSTAL STRUCTURE
1F90H:1-113FAB FRAGMENT OF MONOCLONAL ANTIBODY (LNKB-2) AGAINST HUMAN INTERLEUKIN-2 IN COMPLEX WITH ANTIGENIC PEPTIDE
1HQ4B:1-113; D:1-113STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4
1KB9J:YEAST CYTOCHROME BC1 COMPLEX
1KC5H:1-116CRYSTAL STRUCTURE OF ANTIBODY PC287 IN COMPLEX WITH PS1 PEPTIDE
1KCRH:1-116CRYSTAL STRUCTURE OF ANTIBODY PC283 IN COMPLEX WITH PS1 PEPTIDE
1KCSH:1-116CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE
1KCUH:1-116CRYSTAL STRUCTURE OF ANTIBODY PC287
1KCVH:1-116CRYSTAL STRUCTURE OF ANTIBODY PC282
1KENH:1-120; T:1-120INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH AN ANTIBODY THAT PREVENTS THE HEMAGGLUTININ LOW PH FUSOGENIC TRANSITION
1KYOJ:; U:YEAST CYTOCHROME BC1 COMPLEX WITH BOUND SUBSTRATE CYTOCHROME C
1NCWH:1-113CATIONIC CYCLIZATION ANTIBODY 4C6 IN COMPLEX WITH BENZOIC ACID
1ND0B:1-113; D:1-113; F:1-113; H:1-113CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
1NSNH:1-114THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION
1ORQB:1-118X-RAY STRUCTURE OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL IN COMPLEX WITH AN FAB
1ORSB:1-118X-RAY STRUCTURE OF THE KVAP POTASSIUM CHANNEL VOLTAGE SENSOR IN COMPLEX WITH AN FAB
1P84J:HDBT INHIBITED YEAST CYTOCHROME BC1 COMPLEX
1RU9H:1-113CRYSTAL STRUCTURE (A) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED IN-HOUSE.
1RUAH:1-113CRYSTAL STRUCTURE (B) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1.
1RUKH:1-113CRYSTAL STRUCTURE (C) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1
1RULH:1-113CRYSTAL STRUCTURE (D) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 5.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1.
1RUMH:1-113CRYSTAL STRUCTURE (F) OF H2O2-SOAKED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1.
1RUPH:1-113CRYSTAL STRUCTURE (G) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT APS BEAMLINE 19-ID
1S5IH:1-113FAB (LNKB-2) OF MONOCLONAL ANTIBODY TO HUMAN INTERLEUKIN-2, CRYSTAL STRUCTURE
2A0LD:1-116; F:1-116CRYSTAL STRUCTURE OF KVAP-33H1 FV COMPLEX
2F58H:1-113IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120) (MN ISOLATE)
2IBZX:YEAST CYTOCHROME BC1 COMPLEX WITH STIGMATELLIN
32C2B:1-119STRUCTURE OF AN ACTIVITY SUPPRESSING FAB FRAGMENT TO CYTOCHROME P450 AROMATASE
3CX5J:; U:STRUCTURE OF COMPLEX III WITH BOUND CYTOCHROME C IN REDUCED STATE AND DEFINITION OF A MINIMAL CORE INTERFACE FOR ELECTRON TRANSFER.
3CXHJ:; U:STRUCTURE OF YEAST COMPLEX III WITH ISOFORM-2 CYTOCHROME C BOUND AND DEFINITION OF A MINIMAL CORE INTERFACE FOR ELECTRON TRANSFER.
3F58H:1-113IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120 (MN ISOLATE); H315S MUTATION
(-)
Mouse (Mus musculus), cluster 7.2 [TaxId: 10090] (31)
1C08B:CRYSTAL STRUCTURE OF HYHEL-10 FV-HEN LYSOZYME COMPLEX
1DQDH:1-122CRYSTAL STRUCTURE OF FAB HGR-2 F6, A COMPETITIVE ANTAGONIST OF THE GLUCAGON RECEPTOR
1DQJB:1-113CRYSTAL STRUCTURE OF THE ANTI-LYSOZYME ANTIBODY HYHEL-63 COMPLEXED WITH HEN EGG WHITE LYSOZYME
1DQMH:2-113CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY
1DQQB:1-113; D:1-113CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63
1IC4H:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HD32A)-HEN LYSOZYME COMPLEX
1IC5H:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HD99A)-HEN LYSOZYME COMPLEX
1IC7H:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HD32A99A)-HEN LYSOZYME COMPLEX
1J1OH:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LY50F COMPLEXED WITH HEN EGG WHITE LYSOZYME
1J1PH:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LS91A COMPLEXED WITH HEN EGG WHITE LYSOZYME
1J1XH:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LS93A COMPLEXED WITH HEN EGG WHITE LYSOZYME
1NAKH:1-113; I:1-113IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
1NBYB:301-413CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K96A
1NBZB:301-413CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K97A
1NDGB:301-413CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-8 COMPLEXED WITH ITS ANTIGEN LYSOZYME
1NDMB:301-413CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-26 COMPLEXED WITH LYSOZYME
1OSPH:1-120CRYSTAL STRUCTURE OF OUTER SURFACE PROTEIN A OF BORRELIA BURGDORFERI COMPLEXED WITH A MURINE MONOCLONAL ANTIBODY FAB
1UA6H:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT SFSF COMPLEXED WITH HEN EGG WHITE LYSOZYME COMPLEX
1UACH:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT SFSF COMPLEXED WITH TURKEY WHITE LYSOZYME
2DQCH:1-114CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HY33F) COMPLEXED WITH HEN EGG LYSOZYME
2DQDH:1-114CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (HY50F) COMPLEXED WITH HEN EGG LYSOZYME
2DQEH:1-114CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (HY53A) COMPLEXED WITH HEN EGG LYSOZYME
2DQFB:1-114; E:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (Y33AY53A) COMPLEXED WITH HEN EGG LYSOZYME
2DQGH:1-114CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (HY53F) COMPLEXED WITH HEN EGG LYSOZYME
2DQHH:1-114CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (HY58A) COMPLEXED WITH HEN EGG LYSOZYME
2DQIH:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (LY50A) COMPLEXED WITH HEN EGG LYSOZYME
2DQJH:CRYSTAL STRUCTURE OF HYHEL-10 FV (WILD-TYPE) COMPLEXED WITH HEN EGG LYSOZYME AT 1.8A RESOLUTION
3A67H:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LN31D COMPLEXED WITH HEN EGG WHITE LYSOZYME
3A6BH:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LN32D COMPLEXED WITH HEN EGG WHITE LYSOZYME
3A6CH:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LN92D COMPLEXED WITH HEN EGG WHITE LYSOZYME
3HFMH:1-113STRUCTURE OF AN ANTIBODY-ANTIGEN COMPLEX. CRYSTAL STRUCTURE OF THE HY/HEL-10 FAB-LYSOZYME COMPLEX
(-)
Mouse (Mus musculus), cluster 7.3 [TaxId: 10090] (2)
1ACYH:1-112CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV-1
1AI1H:1-112HIV-1 V3 LOOP MIMIC
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (16)
1BEYH:1-121ANTIBODY TO CAMPATH-1H HUMANIZED FAB
1BFOB:1-121; D:1-121; F:1-121; H:1-121CAMPATH-1G IGG2B RAT MONOCLONAL FAB
1C5DB:1-117; H:1-117THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
1CE1H:1-1211.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN
1F3RB:1-123COMPLEX BETWEEN FV ANTIBODY FRAGMENT AND AN ANALOGUE OF THE MAIN IMMUNOGENIC REGION OF THE ACETYLCHOLINE RECEPTOR
1FN4B:1-106; D:1-106CRYSTAL STRUCTURE OF FAB198, AN EFFICIENT PROTECTOR OF ACETYLCHOLINE RECEPTOR AGAINST MYASTHENOGENIC ANTIBODIES
1LK3H:1-119; I:1-119ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
1OAQH:FREE CONFORMATION AB1 OF THE IGE SPE-7
1OARH:; J:; K:; I:FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
1OAUH:; I:; J:; K:FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
1OAXH:; J:FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
1OAYH:; J:ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY
1OAZH:; J:IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
1OCWH:FREE CONFORMATION AB2 OF THE IGE SPE-7
2ARJB:1-113; H:1-113CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
2BJMH:SPE7:ANTHRONE COMPLEX
(-)
Synthetic construct [TaxId: 32630] (3)
2JIXD:1-116; F:1-116; H:1-116CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
2R0KH:1-113PROTEASE DOMAIN OF HGFA WITH INHIBITOR FAB58
2R0LH:1-113SHORT FORM HGFA WITH INHIBITORY FAB75
(-)
Protein domain: Immunoglobulin light chain kappa variable domain, VL-kappa (616)
(-)
Engineered (including hybrid species) (61)
1AD0A:1-107; C:1-107FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7
1AD9A:1-107; L:1-107IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01
1B2WL:1-107COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY
1BVKA:; D:HUMANIZED ANTI-LYSOZYME FV COMPLEXED WITH LYSOZYME
1BVLB:; D:HUMANIZED ANTI-LYSOZYME FV
1FGVL:X-RAY STRUCTURES OF FRAGMENTS FROM BINDING AND NONBINDING VERSIONS OF A HUMANIZED ANTI-CD18 ANTIBODY: STRUCTURAL INDICATIONS OF THE KEY ROLE OF VH RESIDUES 59 TO 65
1FVCA:; C:X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
1FVDA:1-107; C:1-107X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
1FVEA:1-107; C:1-107X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
1GPOL:1-112; M:1-112CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
1I9RL:1-111; M:1-111; Y:1-111STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
1IT9L:1-111CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT FROM A HUMANIZED VERSION OF THE ANTI-HUMAN FAS ANTIBODY HFE7A
1IVLA:; B:THE DE NOVO DESIGN OF AN ANTIBODY COMBINING SITE: CRYSTALLOGRAPHIC ANALYSIS OF THE VL DOMAIN CONFIRMS THE STRUCTURAL MODEL
1JPSL:1-107CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44
1JPTL:1-107CRYSTAL STRUCTURE OF FAB D3H44
1JV5A:ANTI-BLOOD GROUP A FV
1L7IL:1-107CRYSTAL STRUCTURE OF THE ANTI-ERBB2 FAB2C4
1MHPL:2-106; Y:CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY
1N8ZA:1-107CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN HER2 COMPLEXED WITH HERCEPTIN FAB
1OM3L:2-107; M:2-107FAB 2G12 UNLIGANDED
1OP3K:2-107; L:2-107CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN
1OP5K:2-107; L:2-107CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN9GLCNAC2
1PG7L:1-107; M:1-107MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
1RJLA:1-107STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831
1S3KH:1-119CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE
1S78C:1-107; E:1-107INSIGHTS INTO ERBB SIGNALING FROM THE STRUCTURE OF THE ERBB2-PERTUZUMAB COMPLEX
1T04A:1-108; C:1-108THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP
1T3FA:1-108THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB (HUZAF) IN P21 21 21 SPACE GROUP
1TJGL:1-107CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 7MER EPITOPE
1TJHL:1-107CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 11MER EPITOPE
1TJIL:1-107CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 17MER EPITOPE
1TZHA:1-107; L:1-107CRYSTAL STRUCTURE OF THE FAB YADS1 COMPLEXED WITH H-VEGF
1TZIA:1-107CRYSTAL STRUCTURE OF THE FAB YADS2 COMPLEXED WITH H-VEGF
1U8HA:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWAS
1U8IA:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAN
1U8JA:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAG
1U8KA:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASL
1U8LA:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE DLDRWAS
1U8MA:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKYAS
1U8NA:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKFAS
1U8OA:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKHAS
1U8PA:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ECDKWCS
1U8QA:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELEKWAS
1U91A:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG ENDKW-[DAP]-S (CYCLIC)
1U92A:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG E-[DAP]-DKWQS (CYCLIC)
1U93A:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG EQDKW-[DAP]-S (CYCLIC)
1U95A:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDHWAS
1UJ3A:1-107CRYSTAL STRUCTURE OF A HUMANIZED FAB FRAGMENT OF ANTI-TISSUE-FACTOR ANTIBODY IN COMPLEX WITH TISSUE FACTOR
2F5AL:1-107CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5
2F5BL:1-107CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH ITS GP41 EPITOPE
2FGWL:1-108X-RAY STRUCTURES OF FRAGMENTS FROM BINDING AND NONBINDING VERSIONS OF A HUMANIZED ANTI-CD18 ANTIBODY: STRUCTURAL INDICATIONS OF THE KEY ROLE OF VH RESIDUES 59 TO 65
2IMNA:REFINED CRYSTAL STRUCTURE OF A RECOMBINANT IMMUNOGLOBULIN DOMAIN AND A COMPLEMENTARITY-DETERMINING REGION 1-GRAFTED MUTANT
2PR4L:1-107CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5
3EYVB:1-119; H:1-119ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS
3IDGA:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWD
3IDIA:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ALDKWNQ
3IDJA:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(ORN)WAS
3IDMA:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(NRG)WAS
3IDNA:1-107CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(PAF)WAS
3LEVL:1-107HIV-1 ANTIBODY 2F5 IN COMPLEX WITH EPITOPE SCAFFOLD ES2
3OAUL:2-107ANTIBODY 2G12 RECOGNIZES DI-MANNOSE EQUIVALENTLY IN DOMAIN- AND NON-DOMAIN-EXCHANGED FORMS, BUT ONLY BINDS THE HIV-1 GLYCAN SHIELD IF DOMAIN-EXCHANGED
(-)
Escherichia coli [TaxId: 562] (1)
1XGUA:1-107STRUCTURE FOR ANTIBODY HYHEL-63 Y33F MUTANT COMPLEXED WITH HEN EGG LYSOZYME
(-)
Human (Homo sapiens), cluster 1 [TaxId: 9606] (19)
1AR2A:DISULFIDE-FREE IMMUNOGLOBULIN FRAGMENT
1B0WA:; B:; C:STRUCTURAL COMPARISON OF AMYLOIDOGENIC LIGHT CHAIN DIMER IN TWO CRYSTAL FORMS WITH NONAMYLOIDOGENIC COUNTERPARTS
1B6DA:1-107; B:1-107BENCE JONES PROTEIN DEL: AN ENTIRE IMMUNOGLOBULIN KAPPA LIGHT-CHAIN DIMER
1BREA:; B:; C:; D:; E:; F:IMMUNOGLOBULIN LIGHT CHAIN PROTEIN
1BWWA:; B:BENCE-JONES IMMUNOGLOBULIN REI VARIABLE PORTION, T39K MUTANT
1DEEA:1-107; C:1001-1107; E:2001-2107CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY
1DFBL:1-106STRUCTURE OF A HUMAN MONOCLONAL ANTIBODY FAB FRAGMENT AGAINST GP41 OF HUMAN IMMUNODEFICIENCY VIRUS TYPE I
1DQLL:CRYSTAL STRUCTURE OF AN UNLIGANDED (NATIVE) FV FROM A HUMAN IGM ANTI-PEPTIDE ANTIBODY
1F6LL:VARIABLE LIGHT CHAIN DIMER OF ANTI-FERRITIN ANTIBODY
1HEZA:1-107; C:1-107ANTIBODY-ANTIGEN COMPLEX
1IGML:THREE DIMENSIONAL STRUCTURE OF AN FV FROM A HUMAN IGM IMMUNOGLOBULIN
1QP1A:; B:; C:KAPPA VARIABLE LIGHT CHAIN
1REIA:; B:THE MOLECULAR STRUCTURE OF A DIMER COMPOSED OF THE VARIABLE PORTIONS OF THE BENCE-JONES PROTEIN REI REFINED AT 2.0 ANGSTROMS RESOLUTION
1RZ7L:2-107CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 48D
1RZGB:1-107; D:1-107CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
1RZIA:2-107; C:1-107; E:2-107; G:2-107; I:2-107; K:2-107; M:2-107; O:2-107CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
1VGEL:1-107TR1.9 FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY
1WTLA:; B:COMPARISON OF CRYSTAL STRUCTURES OF TWO HOMOLOGOUS PROTEINS: STRUCTURAL ORIGIN OF ALTERED DOMAIN INTERACTIONS IN IMMUNOGLOBULIN LIGHT CHAIN DIMERS
4DVRL:2-106CRYSTAL STRUCTURE OF YU2 GP120 CORE IN COMPLEX WITH FAB 48D AND NBD-557
(-)
Human (Homo sapiens), cluster 2 [TaxId: 9606] (10)
1EEQA:; B:M4L/Y(27D)D/T94H MUTANT OF LEN
1EEUA:; B:M4L/Y(27D)D/Q89D/T94H MUTANT OF LEN
1EFQA:Q38D MUTANT OF LEN
1EK3A:; B:KAPPA-4 IMMUNOGLOBULIN VL, REC
1LVEA:STRUCTURE OF THE VARIABLE DOMAIN OF HUMAN IMMUNOGLOBULIN K-4 LIGHT CHAIN LEN
1QACA:; B:CHANGE IN DIMERIZATION MODE BY REMOVAL OF A SINGLE UNSATISFIED POLAR RESIDUE
2LVEA:RECOMBINANT LEN
3LVEA:LEN Q38E MUTANT: A DOMAIN FLIP FROM A SINGLE AMINO ACID SUBSTITUTION
4LVEA:; B:LEN K30T MUTANT: A DOMAIN FLIP AS A RESULT OF A SINGLE AMINO ACID SUBSTITUTION
5LVEA:STRUCTURE OF THE VARIABLE DOMAIN OF HUMAN IMMUNOGLOBULIN K-4 LIGHT CHAIN LEN
(-)
Human (Homo sapiens), cluster 3.1 [TaxId: 9606] (8)
1DN0A:1-107; C:1-107STRUCTURE OF THE FAB FRAGMENT FROM A HUMAN IGM COLD AGGLUTININ
1HZHL:1-107; M:1-107CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN
1IQDA:2-108HUMAN FACTOR VIII C2 DOMAIN COMPLEXED TO HUMAN MONOCLONAL BO2C11 FAB.
1N0XL:1-107; M:1-107CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE
1QLRA:1-107; C:1-107CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A HUMAN MONOCLONAL IGM COLD AGGLUTININ
2BRRL:1-107; X:2-107COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)
2GHWB:132-240; D:132-245CRYSTAL STRUCTURE OF SARS SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY, 80R
2NY7L:1-107HIV-1 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH THE BROADLY NEUTRALIZING CD4-BINDING-SITE ANTIBODY B12
(-)
Human (Homo sapiens), cluster 3.2 [TaxId: 9606] (31)
1G9ML:1-109HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1G9NL:1-109HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1GC1L:1-109HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY
1RHHA:1-106A; C:1-106ACRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION
1RZ8A:1-109; C:1-109CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B
1RZJL:1-109HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1RZKL:1-109HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1Y0LA:1-107; C:1-107; E:1-107; L:1-107CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN
1Y18A:1-107; C:1-107; E:1-107; L:1-107FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN
1YYLL:1-107; Q:1001-1107CRYSTAL STRUCTURE OF CD4M33, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
1YYML:1-107; Q:1001-1107CRYSTAL STRUCTURE OF F23, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2B4CL:1-107CRYSTAL STRUCTURE OF HIV-1 JR-FL GP120 CORE PROTEIN CONTAINING THE THIRD VARIABLE REGION (V3) COMPLEXED WITH CD4 AND THE X5 ANTIBODY
2FX7L:1-107CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 16-RESIDUE PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
2FX8L:1-107; M:1-107; N:1-107; O:1-107CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
2FX9L:1-107; M:1-107CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
2I5YL:1-107; Q:1-107CRYSTAL STRUCTURE OF CD4M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2I60L:1-107; Q:1-107CRYSTAL STRUCTURE OF [PHE23]M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2NXYC:2001-2111HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NXZC:2001-2111HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T257S, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY0C:2001-2111HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, T257S, V275C, S334A, S375W, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY1C:2001-2111HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C, T257S, S334A, S375W, Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY2C:2001-2111HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T123C, T257S, S334A, S375W, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY3C:2001-2111HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E267C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY4C:2001-2111HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E268C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY5L:2001-2111HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY6C:2001-2111HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2QR0A:1-107; E:1-107; G:1-107; K:1-107; M:1-107; Q:1-107; S:1-107; W:1-107STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
2QSCL:3-107CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3-FAB F425-B4E8 IN COMPLEX WITH A V3-PEPTIDE
3CFKA:1-107; C:1-107; E:1-107; G:1-107; J:1-107; L:1-107; M:1-107; O:1-107CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM
3DVGA:5-109CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU.3A8 BOUND TO K63-LINKED DI-UBIQUITIN
3DVNA:5-109; L:5-109CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU2.16 BOUND TO K63-LINKED DI-UBIQUITIN
(-)
Mouse (Mus musculus), cluster 1.1 [TaxId: 10090] (131)
1A3LL:1-107CATALYSIS OF A DISFAVORED REACTION: AN ANTIBODY EXO DIELS-ALDERASE-TSA-INHIBITOR COMPLEX AT 1.95 A RESOLUTION
1A4JA:1-112; L:1-112DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
1A4KA:1-112; L:1-112DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
1AE6L:1-106AIGG-FAB FRAGMENT OF MOUSE MONOCLONAL ANTIBODY CTM01
1AXTL:1-107IMMUNE VERSUS NATURAL SELECTION: ANTIBODY ALDOLASES WITH THE RATES OF NATURAL ENZYMES
1BFVL:MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
1BLNA:1-107; C:1-107ANTI-P-GLYCOPROTEIN FAB MRK-16
1C1EL:1-112CRYSTAL STRUCTURE OF A DIELS-ALDERASE CATALYTIC ANTIBODY 1E9 IN COMPLEX WITH ITS HAPTEN
1CBVL:1-112AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE-FAB COMPLEX
1CFVL:MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
1CGSL:1-112LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
1CL7L:1-107ANTI HIV1 PROTEASE FAB
1CLYL:3-108IGG FAB (HUMAN IGG1, KAPPA) CHIMERIC FRAGMENT (CBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
1CLZL:1-108IGG FAB (IGG3, KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
1CR9L:1-106ACRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4
1CU4L:1-106ACRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4 IN COMPLEX WITH ITS PEPTIDE EPITOPE
1DBAL:1-107THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB' AND PROGESTERONE-FAB' COMPLEX
1DBBL:1-107THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB' AND PROGESTERONE-FAB' COMPLEX
1DBJL:1-107MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1DBKL:1-107MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1DBML:1-107MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1DLFL:HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 5.25
1DSFL:THE CRYSTAL STRUCTURE OF THE DISULFIDE-STABILIZED FV FRAGMENT OF ANTICANCER ANTIBODY B1: CONFORMATIONAL INFLUENCE OF AN ENGINEERED DISULFIDE BOND
1EHLL:1-10764M-2 ANTIBODY FAB COMPLEXED WITH D(5HT)(6-4)T
1F3DJ:1-107; L:1-107CATALYTIC ANTIBODY 4B2 IN COMPLEX WITH ITS AMIDINIUM HAPTEN.
1F8TL:1-107FAB (LNKB-2) OF MONOCLONAL ANTIBODY, CRYSTAL STRUCTURE
1F90L:1-107FAB FRAGMENT OF MONOCLONAL ANTIBODY (LNKB-2) AGAINST HUMAN INTERLEUKIN-2 IN COMPLEX WITH ANTIGENIC PEPTIDE
1FL3B:2-113; L:2-113CRYSTAL STRUCTURE OF THE BLUE FLUORESCENT ANTIBODY (19G2) IN COMPLEX WITH STILBENE HAPTEN AT 277K
1FL5A:1-107; L:1-107THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4.
1FL6A:1-107; L:1-107THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
1FLRL:1-1124-4-20 FAB FRAGMENT
1FPTL:1-108THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN THE FAB FRAGMENT OF AN NEUTRALIZING ANTIBODY FOR TYPE 1 POLIOVIRUS AND ITS VIRAL EPITOPE
1I9IL:1-112NATIVE CRYSTAL STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
1I9JL:1-112TESTOSTERONE COMPLEX STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
1IGFL:1-107; M:1-107CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
1IGIL:1-10726-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
1IGJA:1-107; C:1-10726-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
1JGUL:1-107STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4
1JGVL:1-107STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4
1JP5A:1-112; B:1-112CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N-TERMINUS OF HIV-1 PROTEASE
1KEGL:1-107ANTIBODY 64M-2 FAB COMPLEXED WITH DTT(6-4)TT
1KELL:1-112CATALYTIC ANTIBODY 28B4 FAB FRAGMENT COMPLEXED WITH HAPTEN (1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO] METHYLPHOSPHONIC ACID)
1KEML:1-112CATALYTIC ANTIBODY 28B4 FAB FRAGMENT
1KFAL:1-112; M:1-112CRYSTAL STRUCTURE OF FAB FRAGMENT COMPLEXED WITH GIBBERELLIN A4
1KN2L:1-107CATALYTIC ANTIBODY D2.3 COMPLEX
1KN4L:1-107CATALYTIC ANTIBODY D2.3 COMPLEX
1KTRL:CRYSTAL STRUCTURE OF THE ANTI-HIS TAG ANTIBODY 3D5 SINGLE-CHAIN FRAGMENT (SCFV) IN COMPLEX WITH A OLIGOHISTIDINE PEPTIDE
1L7TL:1-112CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB FRAGMENT
1LMKA:201-312; C:201-312; E:201-312; G:201-312THE STRUCTURE OF A BIVALENT DIABODY
1LO0L:1-112; X:1-112CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX
1LO2L:1-112; X:1-112RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY
1LO3L:1-112; X:1-112RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY: PRODUCT ANALOGUE
1LO4L:1-112RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 9D9
1M71A:1-108CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE
1M7DA:1-108CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE
1M7IA:1-108CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A PENTASACCHARIDE
1MAJA:SOLUTION STRUCTURE OF AN ISOLATED ANTIBODY VL DOMAIN
1MAKA:SOLUTION STRUCTURE OF AN ISOLATED ANTIBODY VL DOMAIN
1MH5A:1-107; L:1-107THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
1MIEL:1-107CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393
1MJ7L:1-107CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393 AND A TRANSITION-STATE ANALOG
1MJ8L:1-107HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-126
1MJJA:1-107; L:1-107HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION-STATE ANALOG
1MJUL:1-1071.22 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12
1MNUL:1-112UNLIGANDED BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
1MPAL:1-112BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
1MRCL:1-108PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
1MRDL:1-108PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
1MREL:1-108PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
1MRFL:1-108PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
1N4XL:; M:STRUCTURE OF SCFV 1696 AT ACIDIC PH
1NAKL:1-107; M:1-107IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
1NBVL:1-112AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE-FAB COMPLEX
1NCWL:1-107CATIONIC CYCLIZATION ANTIBODY 4C6 IN COMPLEX WITH BENZOIC ACID
1ND0A:1-107; C:1-107; E:1-107; G:1-107CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
1NLDL:1-107FAB FRAGMENT OF A NEUTRALIZING ANTIBODY DIRECTED AGAINST AN EPITOPE OF GP41 FROM HIV-1
1NQBA:121-233; C:121-233TRIVALENT ANTIBODY FRAGMENT
1PLGL:1-112EVIDENCE FOR THE EXTENDED HELICAL NATURE OF POLYSACCHARIDE EPITOPES. THE 2.8 ANGSTROMS RESOLUTION STRUCTURE AND THERMODYNAMICS OF LIGAND BINDING OF AN ANTIGEN BINDING FRAGMENT SPECIFIC FOR ALPHA-(2->8)-POLYSIALIC ACID
1PZ5A:1-107STRUCTURAL BASIS OF PEPTIDE-CARBOHYDRATE MIMICRY IN AN ANTIBODY COMBINING SITE
1Q72L:1-107ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE
1QFUL:1-106BINFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
1QKZL:1-107FAB FRAGMENT (MN14C11.6) IN COMPLEX WITH A PEPTIDE ANTIGEN DERIVED FROM NEISSERIA MENINGITIDIS P1.7 SEROSUBTYPE ANTIGEN AND DOMAIN II FROM STREPTOCOCCAL PROTEIN G
1QYGL:1-107ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE
1RFDL:1-107ANTI-COCAINE ANTIBODY M82G2
1RIUL:1-107ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE
1RIVL:1-107ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META-OXYBENZOYLECGONINE
1RMFL:1-112STRUCTURES OF A MONOCLONAL ANTI-ICAM-1 ANTIBODY R6.5 FRAGMENT AT 2.8 ANGSTROMS RESOLUTION
1RU9L:1-107CRYSTAL STRUCTURE (A) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED IN-HOUSE.
1RUAL:1-107CRYSTAL STRUCTURE (B) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1.
1RUKL:1-107CRYSTAL STRUCTURE (C) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1
1RULL:1-107CRYSTAL STRUCTURE (D) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 5.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1.
1RUML:1-107CRYSTAL STRUCTURE (F) OF H2O2-SOAKED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1.
1RUPL:1-107CRYSTAL STRUCTURE (G) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT APS BEAMLINE 19-ID
1RUQL:1-107CRYSTAL STRUCTURE (H) OF U.V.-IRRADIATED DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED IN HOUSE.
1RURL:1-107CRYSTAL STRUCTURE (I) OF NATIVE DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1.
1S3KL:1-112CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE
1S5IL:1-107FAB (LNKB-2) OF MONOCLONAL ANTIBODY TO HUMAN INTERLEUKIN-2, CRYSTAL STRUCTURE
1SVZA:1-112; B:1-112CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N-TERMINUS OF HIV-2 PROTEASE
1T66C:1-112; L:1-112THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
1TETL:1-107CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS
1UB5B:1-113; L:1-113CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH HAPTEN AT 100K
1UB6B:2-113; L:2-113CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH SERA LIGAND
1UCBL:4-108STRUCTURE OF UNCOMPLEXED FAB COMPARED TO COMPLEX (1CLY, 1CLZ)
1UZ6E:1-106; L:1-106; M:1-106; V:1-106ANTI-LEWIS X FAB FRAGMENT UNCOMPLEXED
1UZ8A:1-106; L:1-106ANTI-LEWIS X FAB FRAGMENT IN COMPLEX WITH LEWIS X
1VPOL:1-112CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB IN COMPLEX WITH TESTOSTERONE
1WZ1L:CRYSTAL STRUCTURE OF THE FV FRAGMENT COMPLEXED WITH DANSYL-LYSINE
1YECL:1-107STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.3)
1YEDA:1-107; L:1-107STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
1YEEL:1-107STRUCTURE OF A CATALYTIC ANTIBODY, IGG2A FAB FRAGMENT (D2.5)
1YEFL:1-107STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH SUBSTRATE ANALOGUE
1YEGL:1-107STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH REACTION PRODUCT
1YEHL:1-107STRUCTURE OF IGG2A FAB FRAGMENT
1YEIL:1-107CATALYTIC ANTIBODY D2.3 COMPLEX
1YEJL:1-107CATALYTIC ANTIBODY COMPLEX
1YEKL:1-107CATALYTIC ANTIBODY D2.3 COMPLEX
1YNKL:1-107IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETENERS: CRYSTAL STRUCTURE OF NC6.8 CO-CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647
1YNLL:1-107IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETERNERS: CRYSTAL STRUCTURE OF NC6.8 CO-CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647
2BFVL:MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
2CGRL:1-112LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
2DBLL:1-107MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
2DLFL:HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 6.75
2H1PL:1-113THE THREE-DIMENSIONAL STRUCTURES OF A POLYSACCHARIDE BINDING ANTIBODY TO CRYPTOCOCCUS NEOFORMANS AND ITS COMPLEX WITH A PEPTIDE FROM A PHAGE DISPLAY LIBRARY: IMPLICATIONS FOR THE IDENTIFICATION OF PEPTIDE MIMOTOPES
2IGFL:1-107CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
2JELL:1-108JEL42 FAB/HPR COMPLEX
2MPAL:1-112BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
2OJZL:1-107; M:1-107ANTI-DNA ANTIBODY ED10
2OK0L:1-107FAB ED10-DNA COMPLEX
2PCPA:1-107; C:1-107ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
3EYVA:1-112; L:1-112ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS
4FABL:1-112THREE-DIMENSIONAL STRUCTURE OF A FLUORESCEIN-FAB COMPLEX CRYSTALLIZED IN 2-METHYL-2,4-PENTANEDIOL
(-)
Mouse (Mus musculus), cluster 1.2 [TaxId: 10090] (46)
1A3RL:1-114FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID PROTEIN VP2 (RESIDUES 156-170)
1A5FL:1-113FAB FRAGMENT OF A MONOCLONAL ANTI-E-SELECTIN ANTIBODY
1AP2A:; C:SINGLE CHAIN FV OF C219
1BBDL:1-114THREE DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY TO HUMAN RHINOVIRUS SEROTYPE 2
1CK0L:1-107ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, UNLIGANDED FORM
1FRGL:1-113CRYSTAL STRUCTURE, SEQUENCE, AND EPITOPE MAPPING OF A PEPTIDE COMPLEX OF AN ANTI-INFLUENZA HA PEPTIDE ANTIBODY FAB 26(SLASH)9: FINE-TUNING ANTIBODY SPECIFICITY
1H3PL:1-107STRUCTURAL CHARACTERISATION OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE PRES1 REGION OF THE HEPATITIS B VIRUS
1HILA:1-108; C:1-108STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIGEN-ANTIBODY RECOGNITION
1HIMH:1-108; J:1-108STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIBODY-ANTIGEN RECOGNITION
1HINL:1-108STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIBODY-ANTIGEN RECOGNITION
1IFHL:1-108A DETAILED ANALYSIS OF THE FREE AND BOUND CONFORMATION OF AN ANTIBODY: X-RAY STRUCTURES OF ANTI-PEPTIDE FAB 17(SLASH)9 AND THREE DIFFERENT FAB-PEPTIDE COMPLEXES
1IL1B:1-112CRYSTAL STRUCTURE OF G3-519, AN ANTI-HIV MONOCLONAL ANTIBODY
1MCPL:1-114PHOSPHOCHOLINE BINDING IMMUNOGLOBULIN FAB MC/PC603. AN X-RAY DIFFRACTION STUDY AT 2.7 ANGSTROMS
1MHHA:1-107; C:1-107ANTIBODY-ANTIGEN COMPLEX
1MVUA:SINGLE CHAIN FV OF C219 HEAVY CHAIN V101L MUTANT IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
1N64L:1-107CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6
1NLBL:1-107CRYSTAL STRUCTURE OF ANTI-HCV MONOCLONAL ANTIBODY 19D9D6
1PKQA:1-107; F:1-107MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX
1Q9KA:1-107S25-2 FAB UNLIGANDED 1
1Q9LA:1-107; C:1-107S25-2 FAB UNLIGANDED 2
1Q9OA:1-107; C:1-107S45-18 FAB UNLIGANDED
1Q9WA:1-107; C:1-107S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
1SBSL:1-113CRYSTAL STRUCTURE OF AN ANTI-HCG FAB
1T4KA:1-107; C:1-107CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
1YMHA:1-107; C:1-107ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
2AP2A:; C:SINGLE CHAIN FV OF C219 IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
2CK0L:1-107ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, COMPLEX WITH A SYNTHETIC CYCLIC PEPTIDE
2DTG  [entry was replaced by entry 4ZXB without any SCOP domain information]
2IMMA:REFINED CRYSTAL STRUCTURE OF A RECOMBINANT IMMUNOGLOBULIN DOMAIN AND A COMPLEMENTARITY-DETERMINING REGION 1-GRAFTED MUTANT
2MCPL:1-114REFINED CRYSTAL STRUCTURE OF THE MC/PC603 FAB-PHOSPHOCHOLINE COMPLEX AT 3.1 ANGSTROMS RESOLUTION
2R1WA:1-107CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R1XA:1-107CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R1YA:1-107CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R23A:1-107CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R2BA:1-107CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R2EA:1-107CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R2HA:1-107STRUCTURE OF S25-2 IN COMPLEX WITH KO
3BPCA:1-107CO-CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH 5-DEOXY-4-EPI-2,3-DEHYDRO KDO (4.8) KDO
3CK0L:1-107ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, COMPLEX WITH HUMAN ANGIOTENSIN II
3SY0A:1-107S25-2- A(2-8)-A(2-4)KDO TRISACCHARIDE COMPLEX
3T4YA:1-107S25-2- KDO MONOSACCHARIDE COMPLEX
3T65A:1-107S25-2- A(2-8)KDO DISACCHARIDE COMPLEX
3T77A:1-107S25-2- A(2-4)KDO DISACCHARIDE COMPLEX
43C9A:; C:; E:; G:CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY
43CAA:; C:; E:; G:CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY WITH BOUND P-NITROPHENOL
4HGWA:1-107CRYSTAL STRUCTURE OF S25-2 IN COMPLEX WITH A 5,6-DEHYDRO-KDO DISACCHARIDE
(-)
Mouse (Mus musculus), cluster 2 [TaxId: 10090] (28)
1ACYL:1-108CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV-1
1AFVL:1-112; M:1-112HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
1AI1L:1-108HIV-1 V3 LOOP MIMIC
1EGJL:1-107DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY
1EJOL:2001-2111FAB FRAGMENT OF NEUTRALISING MONOCLONAL ANTIBODY 4C4 COMPLEXED WITH G-H LOOP FROM FMDV.
1F11A:1-107; C:1-107F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY
1F58L:1-107IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 24-RESIDUE PEPTIDE (RESIDUES 308-333 OF HIV-1 GP120 (MN ISOLATE) WITH ALA TO AIB SUBSTITUTION AT POSITION 323
1GGBL:1-107MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY
1GGCL:1-107MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY
1GGIL:1-107; M:1-107CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN
1H0DA:1-106CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN IN COMPLEX WITH FAB FRAGMENT OF ITS MONOCLONAL ANTIBODY MAB 26-2F
1I7ZA:1-107; C:1-107ANTIBODY GNC92H2 BOUND TO LIGAND
1IBGL:2-107STRUCTURE AND SPECIFICITY OF THE ANTI-DIGOXIN ANTIBODY 40-50
1IQWL:1-111CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI-HUMAN FAS ANTIBODY HFE7A
1J05A:; L:THE CRYSTAL STRUCTURE OF ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY T84.66 FV FRAGMENT
1MF2L:1-107; M:1-107ANTI HIV1 PROTEASE FAB COMPLEX
1MOEA:1-119; B:1-119THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE.
1NSNL:1-107THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION
1QFWL:TERNARY COMPLEX OF HUMAN CHORIONIC GONADOTROPIN WITH FV ANTI ALPHA SUBUNIT AND FV ANTI BETA SUBUNIT
1QNZL:NMR STRUCTURE OF THE 0.5B ANTI-HIV ANTIBODY COMPLEX WITH THE GP120 V3 PEPTIDE
2AABL:1-107STRUCTURAL BASIS OF ANTIGEN MIMICRY IN A CLINICALLY RELEVANT MELANOMA ANTIGEN SYSTEM
2F58L:1-107IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120) (MN ISOLATE)
2GSIA:1-107; C:1-107; E:1-107; G:1-107CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
2HRPL:1-107; M:1-107ANTIGEN-ANTIBODY COMPLEX
2NZ9C:2-111; E:2-111CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
2R69L:1-111CRYSTAL STRUCTURE OF FAB 1A1D-2 COMPLEXED WITH E-DIII OF DENGUE VIRUS AT 3.8 ANGSTROM RESOLUTION
32C2A:1-110STRUCTURE OF AN ACTIVITY SUPPRESSING FAB FRAGMENT TO CYTOCHROME P450 AROMATASE
3F58L:1-107IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120 (MN ISOLATE); H315S MUTATION
(-)
Mouse (Mus musculus), cluster 3.1 [TaxId: 10090] (13)
15C8L:1-107CATALYTIC ANTIBODY 5C8, FREE FAB
1AIFA:1-109; L:1-109ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) FAB FROM MOUSE
1CF8L:1-107CONVERGENCE OF CATALYTIC ANTIBODY AND TERPENE CYCLASE MECHANISMS: POLYENE CYCLIZATION DIRECTED BY CARBOCATION-PI INTERACTIONS
1FIGL:1-108ROUTES TO CATALYSIS: STRUCTURE OF A CATALYTIC ANTIBODY AND COMPARISON WITH ITS NATURAL COUNTERPART
1HQ4A:1-107; C:1-107STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4
1IAIM:1-109IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
1KENL:1-108; U:1-108INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH AN ANTIBODY THAT PREVENTS THE HEMAGGLUTININ LOW PH FUSOGENIC TRANSITION
1OB1A:1-106A; D:1-106ACRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
1ORQA:1-108X-RAY STRUCTURE OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL IN COMPLEX WITH AN FAB
1ORSA:1-107X-RAY STRUCTURE OF THE KVAP POTASSIUM CHANNEL VOLTAGE SENSOR IN COMPLEX WITH AN FAB
25C8L:1-107CATALYTIC ANTIBODY 5C8, FAB-HAPTEN COMPLEX
2A0LC:1-105; E:1-105CRYSTAL STRUCTURE OF KVAP-33H1 FV COMPLEX
35C8L:1-107CATALYTIC ANTIBODY 5C8, FAB-INHIBITOR COMPLEX
(-)
Mouse (Mus musculus), cluster 3.2 [TaxId: 10090] (40)
1AY1L:1-107ANTI TAQ FAB TP7
1BAFL:1-1082.9 ANGSTROMS RESOLUTION STRUCTURE OF AN ANTI-DINITROPHENYL-SPIN-LABEL MONOCLONAL ANTIBODY FAB FRAGMENT WITH BOUND HAPTEN
1BGXL:1-107TAQ POLYMERASE IN COMPLEX WITH TP7, AN INHIBITORY FAB
1BQLL:1-106STRUCTURE OF AN ANTI-HEL FAB FRAGMENT COMPLEXED WITH BOBWHITE QUAIL LYSOZYME
1DQDL:1-106CRYSTAL STRUCTURE OF FAB HGR-2 F6, A COMPETITIVE ANTAGONIST OF THE GLUCAGON RECEPTOR
1EO8L:1-106BINFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
1FORL:1-107STRUCTURE DETERMINATION OF AN FAB FRAGMENT THAT NEUTRALIZES HUMAN RHINOVIRUS AND ANALYSIS OF THE FAB-VIRUS COMPLEX
1MIML:1-105IGG FAB FRAGMENT (CD25-BINDING)
1OTSD:1-106; F:1-106STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL AND FAB COMPLEX
1OTTD:1-106; F:1-106STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148A MUTANT AND FAB COMPLEX
1OTUD:1-106; F:1-106STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148Q MUTANT AND FAB COMPLEX
1PSKL:1-106THE CRYSTAL STRUCTURE OF AN FAB FRAGMENT THAT BINDS TO THE MELANOMA-ASSOCIATED GD2 GANGLIOSIDE
1QOKA:162-267MFE-23 AN ANTI-CARCINOEMBRYONIC ANTIGEN SINGLE-CHAIN FV ANTIBODY
1RVFL:FAB COMPLEXED WITH INTACT HUMAN RHINOVIRUS
1SY6L:1-106CRYSTAL STRUCTURE OF CD3GAMMAEPSILON HETERODIMER IN COMPLEX WITH OKT3 FAB FRAGMENT
1V7ML:1-107; M:1-107HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
1V7NL:1-107; M:1-107; N:1-107; O:1-107HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
1Z3GL:1-106; M:1-106CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
2EXWD:1-105; F:1-105CRYSTAL STRUCTURE OF A ECCLC-FAB COMPLEX IN THE ABSENCE OF BOUND IONS
2EZ0D:1-105; F:1-105CRYSTAL STRUCTURE OF THE S107A/E148Q/Y445A MUTANT OF ECCLC, IN COMPLEX WITH A FAB FRAGMENT
2FECL:1-105; O:1-105STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC-EC1 FROM E.COLI
2FEDD:1-105; F:1-105STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC-EC1 FROM E.COLI
2FEEL:1-105; O:1-105STRUCTURE OF THE CL-/H+ EXCHANGER CLC-EC1 FROM E.COLI IN NABR
2HLFD:1-105; F:1-105STRUCTURE OF THE ESCHERICHIS COLI CLC CHLORIDE CHANNEL Y445E MUTANT AND FAB COMPLEX
2HT2D:1-105; F:1-105STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445H MUTANT AND FAB COMPLEX
2HT3D:1-105; F:1-105STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445L MUTANT AND FAB COMPLEX
2HT4D:1-105; F:1-105STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445W MUTANT AND FAB COMPLEX
2HTKD:1-105; F:1-105STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445A MUTANT AND FAB COMPLEX
2HTLD:1-105; F:1-105STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445F MUTANT AND FAB COMPLEX
2IFFL:1-106STRUCTURE OF AN ANTIBODY-LYSOZYME COMPLEX: EFFECT OF A CONSERVATIVE MUTATION
2OSLB:2-106; L:2-106CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
2Z93D:1-107CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C-ABCD
2ZKHL:1-107HUMAN THROMBOPOIETIN NEUTRALIZING ANTIBODY TN1 FAB
3DETD:1-106; F:1-106STRUCTURE OF THE E148A, Y445A DOUBLY UNGATED MUTANT OF E.COLI CLC_EC1, CL-/H+ ANTIPORTER
3EJZD:1-106; F:1-106STRUCTURE OF E203V MUTANT E.COLI CL-/H+ EXCHANGER, CLC-EC1
4ENED:1-106; F:1-106STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX
4KJQD:1-106; F:1-106STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
4KK8D:1-106; F:1-106STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
4KKLD:1-106; F:1-106STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTA NC CONSTRUCT IN 100MM FLUORIDE
4LOUD:1-106; F:1-106STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE
(-)
Mouse (Mus musculus), cluster 3.3 [TaxId: 10090] (2)
1A6TA:1-107; C:1-107FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE
1CLOL:1-107ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7
(-)
Mouse (Mus musculus), cluster 3.4 [TaxId: 10090] (4)
1E6JL:1-105CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN (P24) IN COMPLEX WITH FAB13B5
1E6OL:1-105CRYSTAL STRUCTURE OF FAB13B5 AGAINST HIV-1 CAPSID PROTEIN P24
2FBJL:1-109REFINED CRYSTAL STRUCTURE OF THE GALACTAN-BINDING IMMUNOGLOBULIN FAB J539 AT 1.95-ANGSTROMS RESOLUTION
2FD6L:1-106ASTRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR IN COMPLEX WITH UROKINASE RECEPTOR AND AN ANTI-UPAR ANTIBODY AT 1.9 A
(-)
Mouse (Mus musculus), cluster 4 [TaxId: 10090] (211)
12E8L:1-107; M:1-1072E8 FAB FRAGMENT
1A0QL:2-10829G11 COMPLEXED WITH PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL] PHOSPHONATE
1A14L:COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 5 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
1A2YA:HEN EGG WHITE LYSOZYME, D18A MUTANT, IN COMPLEX WITH MOUSE MONOCLONAL ANTIBODY D1.3
1A7NL:FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) VARIANT FOR CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL
1A7OL:FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) R96L DELETION MUTANT ON VARIANT FOR CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL
1A7PL:FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) ENGINEERED MUTANT PRO95L->SER ON VARIANT CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL
1A7QL:FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) HIGH AFFINITY EXPRESSED VARIANT CONTAINING SER26L->GLY, ILE29L->THR, GLU81L->ASP, THR97L->SER, PRO240H->LEU, ASP258H->ALA, LYS281H->GLU, ASN283H->ASP AND LEU312H->VAL
1A7RL:FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) VARIANT CHAIN L GLU81->ASP
1AHWA:1-108; D:1-108A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
1AJ7L:1-109IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
1AR1D:STRUCTURE AT 2.7 ANGSTROM RESOLUTION OF THE PARACOCCUS DENITRIFICANS TWO-SUBUNIT CYTOCHROME C OXIDASE COMPLEXED WITH AN ANTIBODY FV FRAGMENT
1AXSA:1-107; L:1-107MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN
1B4JL:1-107COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY
1BBJA:1-109; L:1-109CRYSTAL STRUCTURE OF A CHIMERIC FAB' FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS
1BJ1J:1-107; L:1-107VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
1BM3L:1-107IMMUNOGLOBULIN OPG2 FAB-PEPTIDE COMPLEX
1BOGA:1-107ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-HOMOLOGOUS PEPTIDE
1BZ7A:1-107FAB FRAGMENT FROM MURINE ASCITES
1C08A:CRYSTAL STRUCTURE OF HYHEL-10 FV-HEN LYSOZYME COMPLEX
1C12A:1-107INSIGHT IN ODORANT PERCEPTION: THE CRYSTAL STRUCTURE AND BINDING CHARACTERISTICS OF ANTIBODY FRAGMENTS DIRECTED AGAINST THE MUSK ODORANT TRASEOLIDE
1C5BL:1-107DECARBOXYLASE CATALYTIC ANTIBODY 21D8 UNLIGANDED FORM
1C5CL:1-107DECARBOXYLASE CATALYTIC ANTIBODY 21D8-HAPTEN COMPLEX
1CFNA:1-107ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-RELATED PEPTIDE
1CFQA:1-107ANTI-P24 (HIV-1) FAB FRAGMENT CB41
1CFSA:1-107ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-UNRELATED PEPTIDE
1CFTA:1-107ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-UNRELATED D-PEPTIDE
1CICA:1-107; C:1-107IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
1CT8A:1-107; C:1-107CATALYTIC ANTIBODY 7C8 COMPLEX
1CZ8L:1-107; X:1-107VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
1D5BA:1-107; L:1-107UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY
1D5IL:1-107UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY
1D6VL:1-107CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION
1DQJA:1-107CRYSTAL STRUCTURE OF THE ANTI-LYSOZYME ANTIBODY HYHEL-63 COMPLEXED WITH HEN EGG WHITE LYSOZYME
1DQML:1-107CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY
1DQQA:1-107; C:1-107CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63
1DVFA:; C:IDIOTOPIC ANTIBODY D1.3 FV FRAGMENT-ANTIIDIOTOPIC ANTIBODY E5.2 FV FRAGMENT COMPLEX
1DZBA:201-307; B:201-307CRYSTAL STRUCTURE OF PHAGE LIBRARY-DERIVED SINGLE-CHAIN FV FRAGMENT 1F9 IN COMPLEX WITH TURKEY EGG-WHITE LYSOZYME
1E4WL:1-107CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
1E4XL:1-107; M:1-107CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
1EAPA:1-107CRYSTAL STRUCTURE OF A CATALYTIC ANTIBODY WITH A SERINE PROTEASE ACTIVE SITE
1EMTL:1-107FAB ANTIBODY FRAGMENT OF AN C60 ANTIFULLERENE ANTIBODY
1EZVY:STRUCTURE OF THE YEAST CYTOCHROME BC1 COMPLEX CO-CRYSTALLIZED WITH AN ANTIBODY FV-FRAGMENT
1FAIL:1-108THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9, FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
1FBIL:1-107; P:1-107CRYSTAL STRUCTURE OF A CROSS-REACTION COMPLEX BETWEEN FAB F9.13.7 AND GUINEA-FOWL LYSOZYME
1FDLL:1-107CRYSTALLOGRAPHIC REFINEMENT OF THE THREE-DIMENSIONAL STRUCTURE OF THE FAB D1.3-LYSOZYME COMPLEX AT 2.5-ANGSTROMS RESOLUTION
1FE8L:1-107; M:1-107; N:1-107CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
1FGNL:1-108MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR
1FH5L:2-108CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MONOCLONAL ANTIBODY MAK33
1FJ1A:1-107; C:1-107LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
1FNSL:1-107CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN I546V MUTANT IN COMPLEX WITH THE FUNCTION BLOCKING FAB NMC4
1FSKB:1-107; E:1-107; H:1-107; K:1-107COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
1G7HA:CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3(VLW92A)
1G7IA:CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92F)
1G7JA:CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92H)
1G7LA:CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92S)
1G7MA:CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92V)
1GAFL:1-10948G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
1GHFL:1-107ANTI-ANTI-IDIOTYPE GH1002 FAB FRAGMENT
1H8NA:3-109THREE-DIMENSIONAL STRUCTURE OF ANTI-AMPICILLIN SINGLE CHAIN FV FRAGMENT FROM PHAGE-DISPLAYED MURINE ANTIBODY LIBRARIES
1H8OA:4-111; B:4-112THREE-DIMENSIONAL STRUCTURE OF ANTI-AMPICILLIN SINGLE CHAIN FV FRAGMENT.
1H8SA:4-111; B:4-112THREE-DIMENSIONAL STRUCTURE OF ANTI-AMPICILLIN SINGLE CHAIN FV FRAGMENT COMPLEXED WITH THE HAPTEN.
1HH6A:1-107ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE
1HH9A:1-107ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE
1HI6A:1-107ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE
1HKLL:1-109FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY
1HYSC:1-107CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RNA:DNA
1I3GL:CRYSTAL STRUCTURE OF AN AMPICILLIN SINGLE CHAIN FV, FORM 1, FREE
1I8IA:CRYSTAL STRUCTURE OF DSFV MR1 IN COMPLEX WITH THE PEPTIDE ANTIGEN OF THE MUTANT EPIDERMAL GROWTH FACTOR RECEPTOR, EGFRVIII, AT ROOM TEMPERATURE
1I8KA:CRYSTAL STRUCTURE OF DSFV MR1 IN COMPLEX WITH THE PEPTIDE ANTIGEN OF THE MUTANT EPIDERMAL GROWTH FACTOR RECEPTOR, EGFRVIII, AT LIQUID NITROGEN TEMPERATURE
1I8MA:1-107; L:1-107CRYSTAL STRUCTURE OF A RECOMBINANT ANTI-SINGLE-STRANDED DNA ANTIBODY FRAGMENT COMPLEXED WITH DT5
1IAIL:1-108IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
1IC4L:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HD32A)-HEN LYSOZYME COMPLEX
1IC5L:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HD99A)-HEN LYSOZYME COMPLEX
1IC7L:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HD32A99A)-HEN LYSOZYME COMPLEX
1IGCL:1-108IGG1 FAB FRAGMENT (MOPC21) COMPLEX WITH DOMAIN III OF PROTEIN G FROM STREPTOCOCCUS
1IGTA:1-108; C:1-108STRUCTURE OF IMMUNOGLOBULIN
1IGYA:2-107; C:2-107STRUCTURE OF IMMUNOGLOBULIN
1IKFL:1-107A CONFORMATION OF CYCLOSPORIN A IN AQUEOUS ENVIRONMENT REVEALED BY THE X-RAY STRUCTURE OF A CYCLOSPORIN-FAB COMPLEX
1J1OL:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LY50F COMPLEXED WITH HEN EGG WHITE LYSOZYME
1J1PL:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LS91A COMPLEXED WITH HEN EGG WHITE LYSOZYME
1J1XL:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LS93A COMPLEXED WITH HEN EGG WHITE LYSOZYME
1J5OL:1-107CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE-PRIMER
1JFQL:1-108ANTIGEN-BINDING FRAGMENT OF THE MURINE ANTI-PHENYLARSONATE ANTIBODY 36-71, "FAB 36-71"
1JGLL:1-107CRYSTAL STRUCTURE OF IMMUNOGLOBULIN FAB FRAGMENT COMPLEXED WITH 17-BETA-ESTRADIOL
1JHKL:1-107CRYSTAL STRUCTURE OF THE ANTI-ESTRADIOL ANTIBODY 57-2
1JHLL:THREE-DIMENSIONAL STRUCTURE OF A HETEROCLITIC ANTIGEN-ANTIBODY CROSS-REACTION COMPLEX
1JNLL:1-107CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1JNNL:1-107CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1JRHL:1-107COMPLEX (ANTIBODY/ANTIGEN)
1K4CB:1-107POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF K+
1K4DB:1-107POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+
1K6QL:1-107CRYSTAL STRUCTURE OF ANTIBODY FAB FRAGMENT D3
1KB5L:1-108MURINE T-CELL RECEPTOR VARIABLE DOMAIN/FAB COMPLEX
1KB9K:YEAST CYTOCHROME BC1 COMPLEX
1KC5L:1-107CRYSTAL STRUCTURE OF ANTIBODY PC287 IN COMPLEX WITH PS1 PEPTIDE
1KCRL:1-106CRYSTAL STRUCTURE OF ANTIBODY PC283 IN COMPLEX WITH PS1 PEPTIDE
1KCSL:1-107CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE
1KCUL:1-107CRYSTAL STRUCTURE OF ANTIBODY PC287
1KCVL:1-107CRYSTAL STRUCTURE OF ANTIBODY PC282
1KIPA:FV MUTANT Y(B 32)A (VH DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME
1KIQA:FV MUTANT Y(B 101)F (VH DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME
1KIRA:FV MUTANT Y(A 50)S (VL DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME
1KNOA:1-108; C:1-108; E:1-108CRYSTAL STRUCTURE OF THE COMPLEX OF A CATALYTIC ANTIBODY FAB WITH A TRANSITION STATE ANALOG: STRUCTURAL SIMILARITIES IN ESTERASE-LIKE ABZYMES
1KYOK:; V:YEAST CYTOCHROME BC1 COMPLEX WITH BOUND SUBSTRATE CYTOCHROME C
1MAML:1-108CRYSTAL STRUCTURE TO 2.45 A RESOLUTION OF A MONOCLONAL FAB SPECIFIC FOR THE BRUCELLA A CELL WALL POLYSACCHARIDE ANTIGEN
1MEXL:1-107ANTIBODY CATALYSIS OF A BIMOLECULAR CYCLOADDITION REACTION
1MLBA:1-108MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME
1MLCA:1-108; C:1-108MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME COMPLEXED WITH LYSOZYME
1MQKL:CRYSTAL STRUCTURE OF THE UNLIGANDED FV-FRAGMENT OF THE ANTI-CYTOCHROME C OXIDASE ANTIBODY 7E2
1N5YL:1-107HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
1N6QL:1-107HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
1N7MH:1-107GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN
1NBYA:1-107CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K96A
1NBZA:1-107CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K97A
1NCAL:1-108REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
1NCBL:1-108CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
1NCCL:1-108CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
1NCDL:1-108REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
1NDGA:1-107CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-8 COMPLEXED WITH ITS ANTIGEN LYSOZYME
1NDMA:1-107CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-26 COMPLEXED WITH LYSOZYME
1NGWA:1-107; L:1-107CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
1NGXA:1-107; L:1-107CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
1NGYA:1-107CHIMERIC MATURE FAB 7G12-APO
1NGZA:1-107CHIMERIC GERMLINE FAB 7G12-APO
1NMAL:N9 NEURAMINIDASE COMPLEXES WITH ANTIBODIES NC41 AND NC10: EMPIRICAL FREE-ENERGY CALCULATIONS CAPTURE SPECIFICITY TRENDS OBSERVED WITH MUTANT BINDING DATA
1NMBL:THE STRUCTURE OF A COMPLEX BETWEEN THE NC10 ANTIBODY AND INFLUENZA VIRUS NEURAMINIDASE AND COMPARISON WITH THE OVERLAPPING BINDING SITE OF THE NC41 ANTIBODY
1NMCC:; L:COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
1OAKL:1-107CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB
1OPGL:1-107OPG2 FAB FRAGMENT
1OSPL:1-107CRYSTAL STRUCTURE OF OUTER SURFACE PROTEIN A OF BORRELIA BURGDORFERI COMPLEXED WITH A MURINE MONOCLONAL ANTIBODY FAB
1P2CA:1-107; D:901-1007CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
1P7KA:1-107; L:1-107CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES)
1P84K:HDBT INHIBITED YEAST CYTOCHROME BC1 COMPLEX
1QBLL:1-107FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION
1QBML:1-107FAB E8B ANTIBODY, X-RAY STRUCTURE AT 2.37 ANGSTROMS RESOLUTION
1QFWM:TERNARY COMPLEX OF HUMAN CHORIONIC GONADOTROPIN WITH FV ANTI ALPHA SUBUNIT AND FV ANTI BETA SUBUNIT
1QLEL:CRYO-STRUCTURE OF THE PARACOCCUS DENITRIFICANS FOUR-SUBUNIT CYTOCHROME C OXIDASE IN THE COMPLETELY OXIDIZED STATE COMPLEXED WITH AN ANTIBODY FV FRAGMENT
1R0AL:1-107CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLY TETHERED TO DNA TEMPLATE-PRIMER SOLVED TO 2.8 ANGSTROMS
1R24A:1-107; C:1-107FAB FROM MURINE IGG3 KAPPA
1R3IL:1-107POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+
1R3JA:1-107POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF TL+
1R3KA:1-107POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+
1R3LA:1-107POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+
1RIHL:1-107CRYSTAL STRUCTURE OF FAB 14F7, A UNIQUE ANTI-TUMOR ANTIBODY SPECIFIC FOR N-GLYCOLYL GM3
1S5HA:1-107POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+
1T03L:1-107HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIR TERMINATED TEMPLATE-PRIMER (COMPLEX P)
1UA6L:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT SFSF COMPLEXED WITH HEN EGG WHITE LYSOZYME COMPLEX
1UACL:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT SFSF COMPLEXED WITH TURKEY WHITE LYSOZYME
1UM4L:2-109CATALYTIC ANTIBODY 21H3 WITH HAPTEN
1UM5L:2-109CATALYTIC ANTIBODY 21H3 WITH ALCOHOL SUBSTRATE
1UM6L:2-109CATALYTIC ANTIBODY 21H3
1UWEL:1-107; U:1-107; X:1-107MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1UWGL:1-107; X:1-107MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1VFAA:BOUND WATER MOLECULES AND CONFORMATIONAL STABILIZATION HELP MEDIATE AN ANTIGEN-ANTIBODY ASSOCIATION
1VFBA:BOUND WATER MOLECULES AND CONFORMATIONAL STABILIZATION HELP MEDIATE AN ANTIGEN-ANTIBODY ASSOCIATION
1WEJL:1-107IGG1 FAB FRAGMENT (OF E8 ANTIBODY) COMPLEXED WITH HORSE CYTOCHROME C AT 1.8 A RESOLUTION
1XF2A:1-107; L:1-107STRUCTURE OF FAB DNA-1 COMPLEXED WITH DT3
1XF3A:1-107; L:1-107STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65
1XF4A:1-107; L:1-107STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
1XIWC:; G:CRYSTAL STRUCTURE OF HUMAN CD3-E/D DIMER IN COMPLEX WITH A UCHT1 SINGLE-CHAIN ANTIBODY FRAGMENT
1ZWIB:1-107STRUCTURE OF MUTANT KCSA POTASSIUM CHANNEL
2ATKB:1-107STRUCTURE OF A MUTANT KCSA K+ CHANNEL
2BOBB:1-107POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA)
2DQCL:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HY33F) COMPLEXED WITH HEN EGG LYSOZYME
2DQDL:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (HY50F) COMPLEXED WITH HEN EGG LYSOZYME
2DQEL:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (HY53A) COMPLEXED WITH HEN EGG LYSOZYME
2DQFA:; D:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (Y33AY53A) COMPLEXED WITH HEN EGG LYSOZYME
2DQGL:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (HY53F) COMPLEXED WITH HEN EGG LYSOZYME
2DQHL:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (HY58A) COMPLEXED WITH HEN EGG LYSOZYME
2DQIL:1-107CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (LY50A) COMPLEXED WITH HEN EGG LYSOZYME
2DQJL:CRYSTAL STRUCTURE OF HYHEL-10 FV (WILD-TYPE) COMPLEXED WITH HEN EGG LYSOZYME AT 1.8A RESOLUTION
2DTG  [entry was replaced by entry 4ZXB without any SCOP domain information]
2DWDB:1-107CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN TL+
2DWEB:1-107CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN RB+
2F19L:1-108THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9, FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
2GFBA:1-108; C:1-108; E:1-108; G:1-108; I:1-108; K:1-108; M:1-108; O:1-108CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
2HH0L:2-149STRUCTURE OF AN ANTI-PRP FAB, P-CLONE, IN COMPLEX WITH ITS COGNATE BOVINE PEPTIDE EPITOPE.
2HJFB:1-107POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA)
2HMIC:1-107HIV-1 REVERSE TRANSCRIPTASE/FRAGMENT OF FAB 28/DNA COMPLEX
2HVJB:1-107CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN LOW K+
2HVKB:1-107CRYSTAL STRUCTURE OF THE KCSA-FAB-TBA COMPLEX IN HIGH K+
2IBZY:YEAST CYTOCHROME BC1 COMPLEX WITH STIGMATELLIN
2IH1B:1-107ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
2IH3B:1-107ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
2ITDB:1-107POTASSIUM CHANNEL KCSA-FAB COMPLEX IN BARIUM CHLORIDE
2J88L:2-108HYALURONIDASE IN COMPLEX WITH A MONOCLONAL IGG FAB FRAGMENT
2JK5B:1-107POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K
2NLJA:1-107POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL
2P7TB:1-107CRYSTAL STRUCTURE OF KCSA MUTANT
2Q76A:1-107; C:1-107MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT
2RCSL:1-109IMMUNOGLOBULIN 48G7 GERMLINE FAB-AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
2W0FB:1-107POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM
3A67L:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LN31D COMPLEXED WITH HEN EGG WHITE LYSOZYME
3A6BL:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LN32D COMPLEXED WITH HEN EGG WHITE LYSOZYME
3A6CL:CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LN92D COMPLEXED WITH HEN EGG WHITE LYSOZYME
3CX5K:; V:STRUCTURE OF COMPLEX III WITH BOUND CYTOCHROME C IN REDUCED STATE AND DEFINITION OF A MINIMAL CORE INTERFACE FOR ELECTRON TRANSFER.
3CXHK:; V:STRUCTURE OF YEAST COMPLEX III WITH ISOFORM-2 CYTOCHROME C BOUND AND DEFINITION OF A MINIMAL CORE INTERFACE FOR ELECTRON TRANSFER.
3FB5B:1-107KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112
3FCTA:1-107; C:1-107MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
3GB7B:1-107POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+
3HFML:1-108STRUCTURE OF AN ANTIBODY-ANTIGEN COMPLEX. CRYSTAL STRUCTURE OF THE HY/HEL-10 FAB-LYSOZYME COMPLEX
3IGAB:1-107POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+
3OR6B:1-107ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71Q
3OR7B:1-107ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71I
3STLB:1-107KCSA POTASSIUM CHANNEL MUTANT Y82C WITH CADMIUM BOUND
3STZB:1-107KCSA POTASSIUM CHANNEL MUTANT Y82C WITH NITROXIDE SPIN LABEL
4LBEB:1-107STRUCTURE OF KCSA WITH R122A MUTATION
4LCUB:1-107STRUCTURE OF KCSA WITH E118A MUTATION
4MSWB:1-107Y78 ESTER MUTANT OF KCSA IN HIGH K+
6FABL:1-108THREE-DIMENSIONAL STRUCTURE OF MURINE ANTI-P-AZOPHENYLARSONATE FAB 36-71. 1. X-RAY CRYSTALLOGRAPHY, SITE-DIRECTED MUTAGENESIS, AND MODELING OF THE COMPLEX WITH HAPTEN
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (9)
1BEYL:1-107ANTIBODY TO CAMPATH-1H HUMANIZED FAB
1BFOA:1-107; C:1-107; E:1-107; G:1-107CAMPATH-1G IGG2B RAT MONOCLONAL FAB
1C5DA:1-106; L:1-106THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
1CE1L:1-1071.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN
1F3RB:139-257COMPLEX BETWEEN FV ANTIBODY FRAGMENT AND AN ANALOGUE OF THE MAIN IMMUNOGENIC REGION OF THE ACETYLCHOLINE RECEPTOR
1FN4A:1-107; C:1-107CRYSTAL STRUCTURE OF FAB198, AN EFFICIENT PROTECTOR OF ACETYLCHOLINE RECEPTOR AGAINST MYASTHENOGENIC ANTIBODIES
1LK3L:1-106; M:1-106ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
1ZA3A:1-106; L:1-106THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
2ARJA:1-107; L:1-107CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
(-)
Synthetic construct [TaxId: 32630] (2)
2HWZL:4-106AFAB FRAGMENT OF HUMANIZED ANTI-VIRAL ANTIBODY MEDI-493 (SYNAGIS TM)
2V7NA:1-148; C:1-148; E:1-148; G:1-148UNUSUAL TWINNING IN CRYSTALS OF THE CITS BINDING ANTIBODY FAB FRAGMENT F3P4
(-)
Protein domain: Immunoglobulin light chain lambda variable domain, VL-lambda (89)
(-)
Chinese hamster (Cricetulus griseus) [TaxId: 10029] (1)
1NFDE:2-107; G:2-107AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
(-)
Human (Homo sapiens), cluster 1 [TaxId: 9606] (4)
1CD0A:; B:STRUCTURE OF HUMAN LAMDA-6 LIGHT CHAIN DIMER JTO
1PEWA:; B:HIGH RESOLUTION CRYSTAL STRUCTURE OF JTO2, A MUTANT OF THE NON-AMYLOIDOGENIC LAMBA6 LIGHT CHAIN, JTO
1PW3A:; B:CRYSTAL STRUCTURE OF JTOR68S
2CD0A:; B:STRUCTURE OF HUMAN LAMBDA-6 LIGHT CHAIN DIMER WIL
(-)
Human (Homo sapiens), cluster 2 [TaxId: 9606] (10)
1BJMA:1-111; B:1-111LOC NAKS, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN NAKSO4
1NL0L:1-108CRYSTAL STRUCTURE OF HUMAN FACTOR IX GLA DOMAIN IN COMPLEX OF AN INHIBITORY ANTIBODY, 10C12
1Q1JL:1-108; M:1-108CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE
1RZFL:2-108CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY E51
2FB4L:1-109DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L-KETTE, LAMBDA-TYP, SUBGRUPPE I (GERMAN)
2IG2L:1-109DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L-KETTE, LAMBDA-TYP, SUBGRUPPE I (GERMAN)
2J6EL:1-108CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
2RHEA:STRUCTURE OF A NOVEL BENCE-JONES PROTEIN (RHE) FRAGMENT AT 1.6 ANGSTROMS RESOLUTION
3BJLA:1-111; B:1-111LOC, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN AMMONIUM SULFATE
4BJLA:2-111; B:2-111LOCW, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN DISTILLED WATER
(-)
Human (Homo sapiens), cluster 3.1 [TaxId: 9606] (1)
1AQKL:1-111THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR TETANUS TOXOID
(-)
Human (Homo sapiens), cluster 3.2 [TaxId: 9606] (1)
7FABL:1-103CRYSTAL STRUCTURE OF HUMAN IMMUNOGLOBULIN FRAGMENT FAB NEW REFINED AT 2.0 ANGSTROMS RESOLUTION
(-)
Human (Homo sapiens), cluster 4 [TaxId: 9606] (23)
1A8JH:1-111; L:1-111IMMUNOGLOBULIN LAMBDA LIGHT CHAIN DIMER (MCG) COMPLEX WITH ASPARTAME
1DCLA:1-111; B:1-111MCG, A LAMBDA V TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN), CRYSTALLIZED FROM AMMONIUM SULFATE
1JVKA:1-112; B:1-112THREE-DIMENSIONAL STRUCTURE OF AN IMMUNOGLOBULIN LIGHT CHAIN DIMER ACTING AS A LETHAL AMYLOID PRECURSOR
1LGVA:1-112; B:1-112STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 100K
1LHZA:1-112; B:1-112STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 293K
1MCBA:1-111; B:1-111PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1MCCA:1-111; B:1-111PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1MCDA:1-111; B:1-111PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1MCEA:1-111; B:1-111PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1MCFA:1-111; B:1-111PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1MCHA:1-111; B:1-111PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1MCIA:1-111; B:1-111PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1MCJA:1-111; B:1-111PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1MCKA:1-111; B:1-111PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1MCLA:1-111; B:1-111PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1MCNA:1-111; B:1-111PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1MCOL:1-111THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION
1MCQA:1-111; B:1-111PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1MCRA:1-111; B:1-111PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1MCSA:1-111; B:1-111PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1MCWM:1-111; W:1-111THREE-DIMENSIONAL STRUCTURE OF A HYBRID LIGHT CHAIN DIMER. PROTEIN ENGINEERING OF A BINDING CAVITY
2MCG1:1-111; 2:1-111THREE-DIMENSIONAL STRUCTURE OF A LIGHT CHAIN DIMER CRYSTALLIZED IN WATER. CONFORMATIONAL FLEXIBILITY OF A MOLECULE IN TWO CRYSTAL FORMS
3MCG1:1-111; 2:1-111THREE-DIMENSIONAL STRUCTURE OF A LIGHT CHAIN DIMER CRYSTALLIZED IN WATER. CONFORMATIONAL FLEXIBILITY OF A MOLECULE IN TWO CRYSTAL FORMS
(-)
Human (Homo sapiens), cluster 5 [TaxId: 9606] (7)
1ADQL:2-107CRYSTAL STRUCTURE OF A HUMAN IGM RHEUMATOID FACTOR FAB IN COMPLEX WITH ITS AUTOANTIGEN IGG FC
1LILA:2-107; B:2-107BENCE JONES PROTEIN CLE, A LAMBDA III IMMUNOGLOBULIN LIGHT-CHAIN DIMER
1W72L:1-107; M:1-107CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3
1ZVOA:3-108; B:3-108SEMI-EXTENDED SOLUTION STRUCTURE OF HUMAN MYELOMA IMMUNOGLOBULIN D DETERMINED BY CONSTRAINED X-RAY SCATTERING
2DD8L:3-108CRYSTAL STRUCTURE OF SARS-COV SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH NEUTRALIZING ANTIBODY
2G75B:2-108; D:2-108CRYSTAL STRUCTURE OF ANTI-SARS M396 ANTIBODY
8FABA:3-105; C:3-105CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE HUMAN MYELOMA IMMUNOGLOBULIN IGG HIL AT 1.8 ANGSTROMS RESOLUTION
(-)
Mouse (Mus musculus) [TaxId: 10090] (35)
1A6UL:B1-8 FV FRAGMENT
1A6VL:; M:; N:B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-3-NITROPHENYL) ACETATE COMPOUND
1A6WL:B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-5-IODO-3-NITROPHENYL) ACETATE COMPOUND
1DL7L:THE STRUCTURAL BASIS OF REPERTOIRE SHIFT IN AN IMMUNE RESPONSE TO PHOSPHOCHOLINE
1ETZA:1-110; L:1-110THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB, NC10.14, SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS
1F4WL:1-110CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN
1F4XL:1-110CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN
1F4YL:1-110CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN
1GIGL:1-110REFINED THREE-DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A MURINE IGG1, LAMBDA ANTIBODY
1INDL:2-109HOW THE ANTI-(METAL CHELATE) ANTIBODY CHA255 IS SPECIFIC FOR THE METAL ION OF ITS ANTIGEN: X-RAY STRUCTURES FOR TWO FAB'(SLASH)HAPTEN COMPLEXES WITH DIFFERENT METALS IN THE CHELATE
1INEL:2-109HOW THE ANTI-(METAL CHELATE) ANTIBODY CHA255 IS SPECIFIC FOR THE METAL ION OF ITS ANTIGEN: X-RAY STRUCTURES FOR TWO FAB'(SLASH)HAPTEN COMPLEXES WITH DIFFERENT METALS IN THE CHELATE
1JN6A:1-108CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1JNHA:1-108; C:1-108; E:1-108; G:1-108CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1MFAL:1-111STRUCTURE OF A SINGLE-CHAIN FV FRAGMENT COMPLEXED WITH A CARBOHYDRATE ANTIGEN AT 1.7 ANGSTROMS RESOLUTION
1MFBL:1-111HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
1MFCL:1-111HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
1MFDL:1-111THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE
1MFEL:1-111RECOGNITION OF A CELL-SURFACE OLIGO-SACCHARIDE OF PATHOGENIC SALMONELLA BY AN ANTIBODY FAB FRAGMENT
1NC2A:1-110; C:1-110CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y-DOTA
1NC4A:1-110; C:1-110CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD-DOTA
1NGPL:1-109N1G9 (IGG1-LAMBDA) FAB FRAGMENT COMPLEXED WITH (4-HYDROXY-3-NITROPHENYL) ACETATE
1NGQL:1-109N1G9 (IGG1-LAMBDA) FAB FRAGMENT
1NJ9A:1-108; L:1-108COCAINE HYDROLYTIC ANTIBODY 15A10
1P4BL:THREE-DIMENSIONAL STRUCTURE OF A SINGLE CHAIN FV FRAGMENT COMPLEXED WITH THE PEPTIDE GCN4(7P-14P).
1P4IL:CRYSTAL STRUCTURE OF SCFV AGAINST PEPTIDE GCN4
1PG7W:1-108; Y:1-108MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
1Q0XL:1-107ANTI-MORPHINE ANTIBODY 9B1 UNLIGANDED FORM
1Q0YL:1-107ANTI-MORPHINE ANTIBODY 9B1 COMPLEXED WITH MORPHINE
1SM3L:3-107CRYSTAL STRUCTURE OF THE TUMOR SPECIFIC ANTIBODY SM3 COMPLEX WITH ITS PEPTIDE EPITOPE
1YUHA:2-109; L:2-109FAB FRAGMENT
2BJML:SPE7:ANTHRONE COMPLEX
2VIRA:1-110INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
2VISA:1-110INFLUENZA VIRUS HEMAGGLUTININ, (ESCAPE) MUTANT WITH THR 131 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY
2VITA:1-110INFLUENZA VIRUS HEMAGGLUTININ, MUTANT WITH THR 155 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY
3C6LA:7-109; E:7-109CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR 2W20
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (7)
1OAQL:FREE CONFORMATION AB1 OF THE IGE SPE-7
1OARL:; M:; N:; O:FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
1OAUL:; M:; N:; O:FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
1OAXL:; M:; N:; O:FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
1OAYL:; M:; N:; O:ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY
1OAZL:; N:IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
1OCWL:FREE CONFORMATION AB2 OF THE IGE SPE-7
(-)
Protein domain: Immunoreceptor CTLA-4 (CD152), N-terminal fragment (4)
(-)
Human (Homo sapiens) [TaxId: 9606] (3)
1AH1A:CTLA-4, NMR, 20 STRUCTURES
1I85C:; D:CRYSTAL STRUCTURE OF THE CTLA-4/B7-2 COMPLEX
1I8LC:; D:HUMAN B7-1/CTLA-4 CO-STIMULATORY COMPLEX
(-)
Mouse (Mus musculus) [TaxId: 10090] (1)
1DQTA:; B:; C:; D:THE CRYSTAL STRUCTURE OF MURINE CTLA4 (CD152)
(-)
Protein domain: Junction adhesion molecule, JAM, N-terminal domain (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1NBQA:25-129; B:26-129CRYSTAL STRUCTURE OF HUMAN JUNCTIONAL ADHESION MOLECULE TYPE 1
(-)
Mouse (Mus musculus) [TaxId: 10090] (1)
1F97A:27-128SOLUBLE PART OF THE JUNCTION ADHESION MOLECULE FROM MOUSE
(-)
Protein domain: Kin of IRRE-like protein 3, KIRREL3 (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
2CRYA:8-122SOLUTION STRUCTURE OF THE FIFTH IG-LIKE DOMAIN OF HUMAN KIN OF IRRE LIKE 3
(-)
Protein domain: Myelin membrane adhesion molecule P0 (1)
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (1)
1NEUA:STRUCTURE OF MYELIN MEMBRANE ADHESION MOLECULE P0
(-)
Protein domain: Myelin oligodendrocyte glycoprotein (MOG) (4)
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (4)
1PKOA:MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
1PKQE:; J:MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX
1PY9A:THE CRYSTAL STRUCTURE OF AN AUTOANTIGEN IN MULTIPLE SCLEROSIS
3CSPA:CRYSTAL STRUCTURE OF THE DM2 MUTANT OF MYELIN OLIGODENDROCYTE GLYCOPROTEIN
(-)
Protein domain: N-terminal domain of sialic acid binding Ig-like lectin 7 (SIGLEC-7, p75/AIRM1) (6)
(-)
Human (Homo sapiens) [TaxId: 9606] (6)
1NKOA:ENERGETIC AND STRUCTURAL BASIS OF SIALYLATED OLIGOSACCHARIDE RECOGNITION BY THE NATURAL KILLER CELL INHIBITORY RECEPTOR P75/AIRM1 OR SIGLEC-7
1O7SA:HIGH RESOLUTION STRUCTURE OF SIGLEC-7
1O7VA:HIGH RESOLUTION STRUCTURE OF SIGLEC-7
2DF3A:THE STRUCTURE OF SIGLEC-7 IN COMPLEX WITH ALPHA(2,3)/ALPHA(2,6) DISIALYL LACTOTETRAOSYL 2-(TRIMETHYLSILYL)ETHYL
2G5RA:CRYSTAL STRUCTURE OF SIGLEC-7 IN COMPLEX WITH METHYL-9-(AMINOOXALYL-AMINO)-9-DEOXYNEU5AC (OXAMIDO-NEU5AC)
2HRLA:SIGLEC-7 IN COMPLEX WITH GT1B
(-)
Protein domain: N-terminal domain of sialoadhesin (6)
(-)
Mouse (Mus musculus) [TaxId: 10090] (6)
1OD7A:N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH ME-A-9-N-(NAPHTHYL-2-CARBONYL)-AMINO-9-DEOXY-NEU5AC (NAP COMPOUND)
1OD9A:N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH ME-A-9-N-BENZOYL-AMINO-9-DEOXY-NEU5AC (BENZ COMPOUND)
1ODAA:N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH ME-A-9-N-(BIPHENYL-4-CARBONYL)-AMINO-9-DEOXY-NEU5AC (BIP COMPOUND)
1QFOA:; B:; C:N-TERMINAL DOMAIN OF SIALOADHESIN (MOUSE) IN COMPLEX WITH 3'SIALYLLACTOSE
1QFPA:N-TERMINAL DOMAIN OF SIALOADHESIN (MOUSE)
1URLA:N-TERMINAL DOMAIN OF SIALOADHESIN (MOUSE) IN COMPLEX WITH GLYCOPEPTIDE
(-)
Protein domain: NK cell activating receptor NKP44 (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1HKFA:THE THREE DIMENSIONAL STRUCTURE OF NK CELL RECEPTOR NKP44, A TRIGGERING PARTNER IN NATURAL CYTOTOXICITY
(-)
Protein domain: Novel antigen receptor (against lysozyme) (3)
(-)
Nurse shark (Ginglymostoma cirratum) [TaxId: 7801] (3)
1SQ2N:CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR (NAR) VARIABLE DOMAIN IN COMPLEX WITH LYSOZYME
1T6VN:; O:CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR (NAR) VARIABLE DOMAIN IN COMPLEX WITH LYSOZYME
2I26N:2-113CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR ANCESTRAL VARIABLE DOMAIN IN COMPLEX WITH LYSOZYME
(-)
Protein domain: Novel antigen receptor 12Y-1 (1)
(-)
Spotted wobbegong (Orectolobus maculatus) [TaxId: 168098] (1)
1VERA:STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
(-)
Protein domain: Novel antigen receptor 12Y-2 (1)
(-)
Spotted wobbegong (Orectolobus maculatus) [TaxId: 168098] (1)
1VESA:; B:STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
(-)
Protein domain: Polymeric-immunoglobulin receptor, PIGR (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1XEDA:; B:; C:; D:; E:; F:CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR, PIGR
(-)
Protein domain: Programmed cell death protein 1, PD1, extracellular domain (6)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
2M2DA:HUMAN PROGRAMMED CELL DEATH 1 RECEPTOR
(-)
Mouse (Mus musculus) [TaxId: 10090] (5)
1NPUA:CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MURINE PD-1
3BIKB:; C:CRYSTAL STRUCTURE OF THE PD-1/PD-L1 COMPLEX
3BP5A:CRYSTAL STRUCTURE OF THE MOUSE PD-1 AND PD-L2 COMPLEX
3BP6A:CRYSTAL STRUCTURE OF THE MOUSE PD-1 MUTANT AND PD-L2 COMPLEX
3SBWA:; B:CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EXTRACELLULAR DOMAINS OF MOUSE PD-1 MUTANT AND HUMAN PD-L1
(-)
Protein domain: T-cell antigen receptor (105)
(-)
Human (Homo sapiens), alpha-chain [TaxId: 9606] (21)
1AO7D:COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201
1BD2D:1-117COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201
1FYTD:1-117CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR1
1J8HD:1-117CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR4
1KGCD:2-117IMMUNE RECEPTOR
1MI5D:2-117THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBV PEPTIDE COMPLEX
1OGAD:3-117A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.
1QRND:1-117CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A
1QSED:1-117STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R
1QSFD:1-117STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A
1YMMD:9-104TCR/HLA-DR2B/MBP-PEPTIDE COMPLEX
2AK4D:1-116; I:1-116; N:1-116; T:1-116CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508-13MER PEPTIDE
2BNQD:2-114STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2BNRD:2-114STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2ESVD:4-116STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX
2F53D:1-114DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY
2F54D:1-114; K:1-114DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
3KPRD:2-117; I:2-117CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE
3KPSD:2-117CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
3PWPD:1-117THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
3QFJD:1-117THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
(-)
Human (Homo sapiens), beta-chain [TaxId: 9606] (29)
1AO7E:3-118COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201
1BD2E:3-118COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201
1FYTE:3-118CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR1
1J8HE:2-118CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR4
1KGCE:3-118IMMUNE RECEPTOR
1KTKE:1-118; F:4-116COMPLEX OF STREPTOCOCCAL PYROGENIC ENTEROTOXIN C (SPEC) WITH A HUMAN T CELL RECEPTOR BETA CHAIN (VBETA2.1)
1MI5E:3-118THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBV PEPTIDE COMPLEX
1OGAE:5-118A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.
1QRNE:3-118CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A
1QSEE:3-118STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R
1QSFE:3-118STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A
1YMME:1-119TCR/HLA-DR2B/MBP-PEPTIDE COMPLEX
1ZGLP:3-118; R:3-118; T:3-118; V:3-118CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
2AK4E:3-118; J:3-118; P:3-118; U:3-118CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508-13MER PEPTIDE
2BNQE:2-113STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2BNRE:2-113STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2BNUB:2-113STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2CDEA:2-115; B:5-116; D:5-116; F:5-116STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
2ESVE:3-118STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX
2F53E:1-112DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY
2F54E:1-112; L:1-112DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
2GJ6E:3-117THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
2IJ0C:1-117; E:STRUCTURAL BASIS OF T CELL SPECIFICITY AND ACTIVATION BY THE BACTERIAL SUPERANTIGEN TOXIC SHOCK SYNDROME TOXIN-1
2RCJA:11-116; B:11-116; E:11-116; F:11-116; I:11-116; J:11-116; M:11-116; N:11-116; Q:11-116; R:11-116SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
2VLJE:5-118THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VLKE:5-118THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VLRE:5-118; J:5-118THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
3KPRE:3-118; J:3-118CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE
3KPSE:3-118CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
(-)
Human (Homo sapiens), delta-chain [TaxId: 9606] (3)
1HXMB:1-123; D:1-123; F:1-123; H:1-123CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1TVDA:; B:VARIABLE DOMAIN OF T CELL RECEPTOR DELTA CHAIN
1YPZE:1-119; G:1-119IMMUNE RECEPTOR
(-)
Human (Homo sapiens), gamma-chain [TaxId: 9606] (3)
1HXMA:1-120; C:1-120; E:1-120; G:1-120CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1YPZF:1-120; H:1-120IMMUNE RECEPTOR
2QR0B:12-111; T:12-111; X:12-111; F:12-111; H:12-111; L:12-111; N:12-111; R:12-111STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
(-)
Mouse (Mus musculus), alpha-chain [TaxId: 10090] (21)
1AC6A:; B:CRYSTAL STRUCTURE OF A VARIABLE DOMAIN MUTANT OF A T-CELL RECEPTOR ALPHA CHAIN
1B88A:; B:V-ALPHA 2.6 MOUSE T CELL RECEPTOR (TCR) DOMAIN
1BWMA:301-417A SINGLE-CHAIN T CELL RECEPTOR
1D9KA:; E:CRYSTAL STRUCTURE OF COMPLEX BETWEEN D10 TCR AND PMHC I-AK/CA
1FO0A:MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1G6RA:1-117; C:1-117A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1H5BA:; B:; C:; D:T CELL RECEPTOR VALPHA11 (AV11S5) DOMAIN
1I9EA:TCR DOMAIN
1KB5A:MURINE T-CELL RECEPTOR VARIABLE DOMAIN/FAB COMPLEX
1KJ2A:; D:MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1LP9E:0-117; L:0-117XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
1MWAA:1-117; C:1-1172C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
1NAMA:MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1NFDA:1-117; C:1-117AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
1TCRA:1-117MURINE T-CELL ANTIGEN RECEPTOR 2C CLONE
1U3HA:2-116; E:CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A
2CKBA:1-117; C:1-117STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
2J8UE:0-117; L:0-117LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.
2JCCE:0-117; L:0-117AH3 RECOGNITION OF MUTANT HLA-A2 W167A
2OL3A:1-116CRYSTAL STRUCTURE OF BM3.3 SCFV TCR IN COMPLEX WITH PBM8-H-2KBM8 MHC CLASS I MOLECULE
2UWEE:0-117; L:0-117LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
(-)
Mouse (Mus musculus), beta-chain [TaxId: 10090] (28)
1BECA:3-117BETA CHAIN OF A T CELL ANTIGEN RECEPTOR
1BWMA:3-116AA SINGLE-CHAIN T CELL RECEPTOR
1D9KB:; F:CRYSTAL STRUCTURE OF COMPLEX BETWEEN D10 TCR AND PMHC I-AK/CA
1FO0B:MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1G6RB:1-117; D:1-117A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1JCKA:3-117; C:3-117T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SEC3 SUPERANTIGEN
1KB5B:MURINE T-CELL RECEPTOR VARIABLE DOMAIN/FAB COMPLEX
1KJ2B:; E:MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1L0XA:3-117; C:3-117TCR BETA CHAIN COMPLEXED WITH STREPTOCOCCAL SUPERANTIGEN SPEA
1L0YA:3-117; C:3-117T CELL RECEPTOR BETA CHAIN COMPLEXED WITH SUPERANTIGEN SPEA SOAKED WITH ZINC
1LP9F:1-117; M:1-117XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
1MWAB:1-117; D:1-1172C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
1NAMB:MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1NFDB:1-117; D:1-117AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
1SBBA:3-117; C:3-117T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SUPERANTIGEN SEB
1TCRB:1-117MURINE T-CELL ANTIGEN RECEPTOR 2C CLONE
1U3HB:3-117; F:CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A
2AQ2A:1-117CRYSTAL STRUCTURE OF T-CELL RECEPTOR V BETA DOMAIN VARIANT COMPLEXED WITH SUPERANTIGEN SEC3 MUTANT
2AQ3A:2-117CRYSTAL STRUCTURE OF T-CELL RECEPTOR V BETA DOMAIN VARIANT COMPLEXED WITH SUPERANTIGEN SEC3
2CKBB:1-117; D:1-117STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
2GJ6D:15-114THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
2ICWJ:1-113CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR, SUPERANTIGEN, AND PEPTIDE-MHC CLASS II MOLECULE
2J8UF:1-117; M:1-117LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.
2JCCF:1-117; M:1-117AH3 RECOGNITION OF MUTANT HLA-A2 W167A
2OL3B:CRYSTAL STRUCTURE OF BM3.3 SCFV TCR IN COMPLEX WITH PBM8-H-2KBM8 MHC CLASS I MOLECULE
2UWEF:1-117; M:1-117LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
3RTQD:2-112STRUCTURE OF THE MOUSE CD1D-HS44-INKT TCR COMPLEX
3RZCD:2-112STRUCTURE OF THE SELF-ANTIGEN IGB3 BOUND TO MOUSE CD1D AND IN COMPLEX WITH THE INKT TCR
(-)
Protein domain: TREM-1 (triggering receptor expressed on myeloid cells 1) (3)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1Q8MA:; B:; C:; D:CRYSTAL STRUCTURE OF THE HUMAN MYELOID CELL ACTIVATING RECEPTOR TREM-1
1SMOA:; B:CRYSTAL STRUCTURE OF HUMAN TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1 (TREM-1) AT 1.47 .
(-)
Mouse (Mus musculus) [TaxId: 10090] (1)
1U9KA:; B:CRYSTAL STRUCTURE OF MOUSE TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1 (TREM-1) AT 1.76
(-)
Protein domain: Tyrosine-protein kinase receptor tyro3, N-terminal domain (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1RHFA:7-97; B:7-97CRYSTAL STRUCTURE OF HUMAN TYRO3-D1D2